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ABSTRACT
Shelrud, Anika Brit. Mechanisms behind the luteoprotective effects of fish meal supplementation in
bovine: cytokine sensitivity and luteal blood flow. Unpublished Master of Science Thesis,
University of Northern Colorado, 2022.

Early pregnancy loss continues to be problematic in the cattle industry. A large proportion of the
pregnancy loss occurs during the maternal recognition of pregnancy (MRP) phase of gestation. During the
MRP, a developing conceptus must secrete sufficient interferon tau to inhibit release of the uterinederived and luteolytic mediator, prostaglandin F2 alpha (PGF2𝛼). If successful, the progesteronesecreting corpus luteum (CL) will be maintained, which is necessary for establishment and maintenance
of pregnancy. Pregnancy loss at the point of MRP may be due to a slow developing conceptus that does
not effectively block PGF2𝛼. Therefore, reducing the influence of PGF2𝛼 on the CL may lengthen the
window of time to establish pregnancy. Fish meal (FM) supplementation, rich in the omega-3 fatty acids
eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA), serves as a luteoprotective agent
following PGF2𝛼 exposure; an effect we repeated here. However, the mechanistic actions of FM
supplementation are not yet apparent. Here, we postulated two mechanisms by which FM
supplementation (and components) reduces rates of luteal regression: 1) EPA and DHA protect cells
against the cytotoxic effects of TNF𝛼 and IFN𝛾 and (or) 2) FM supplementation maintains luteal blood
flow in functional CL 48 hrs following exposure to PGF2𝛼. We found that EPA and DHA did not protect
cells from the cytotoxic effects of TNF𝛼 and IFN𝛾 exposure, although omega-3 fatty acids altered
transcriptional regulation of necroptotic cell death in cells of an early and middle-stage CL. Moreover, we
demonstrated that cells of a middle stage CL are less sensitive to the cytotoxic effects of TNF𝛼 and IFN𝛾,
which may be due to reduced expression of TNFRI. Exposure to TNF𝛼 and IFN𝛾 increased expression of
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TNF𝛼 and NFkB, and reduced expression of steroidogenic genes STARD1 and CYP11A1. With respect to
our second postulated mechanism, we found no change in luteal blood flow 48 hrs following PGF2𝛼
exposures, as detected with power Doppler ultrasonography. However, we did find that FM-PGF2𝛼
infused cows had a significant reduction in luteal hyperemia when compared to the control
supplementation, indicating FM supplementation may be altering the acute blood flow response. In
conclusion, the differing micro-environments of each luteal stage pre-conditions cellular sensitivity to
TNF𝛼 and IFN𝛾 exposure. Moreover, FM supplementation may maintain functional CL by blunting the
acute changes in luteal blood flow during luteal regression.
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CHAPTER I
REVIEW OF THE LITERATURE
The Estrous Cycle
The estrous cycle (EC) of the female bovid (cow) encompasses the endocrine and
physiological changes that occur from one bout of estrus to the next. In healthy, non-pregnant
cattle, the length of the estrous cycle is approximately 18-24 days (Hammond, 1927). The
function of the EC, like all reproductive cycles, is to provide the cow with an opportunity for
pregnancy through the production and release of an oocyte. The EC is divided into four distinct
behavioural phases: estrus (day 0), metestrus (day 1-5), diestrus (day 6-17), and proestrus (day
18-24; figure 1.1). The EC can further be divided into two subcategories with respect to the
dominating ovarian structure; the follicular phase precedes when a dominant follicle is the
primary ovarian structure (day 18-0 [-4 to 0] of the EC), and the luteal phase precedes when a
corpus luteum (CL; to be further defined) is the primary ovarian structure (days 1-17 of the EC).
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Figure 1.1
The Bovine Estrous Cycle

Note. Changes in endocrine hormones— luteinizing hormone (LH), Follicle stimulating hormone
(FSH), estradiol (E2), and progesterone (P4)— during each phase of the estrous cycle. If no
pregnancy is detected, prostaglandin F2 alpha (PGF2α) is released from the uterus and induces
regression of the corpus luteum.
Estrus
Estrus— also termed standing estrus, standing heat, or heat—begins on day 0 of the EC
and persists for approximately 12 hrs. Ovulation will occur approximately 24 to 32 hrs following
onset of estrus. Estrus behaviour is stimulated by elevated circulation of the sex hormone
estradiol. This hormone stimulates behavioural and physiological changes, namely: standing to
be mounted (lordosis), mounting other cows, agitation, anorexia, increased vocalization, licking,
mucus secretions from the vulva, vulva enlargement and increased rectal temperatures (Bane &
Rajakoski, 1961).
The hypothalamic-pituitary-gonadal axis is an endocrine feedback loop responsible for
the regulation of the EC. At the onset of estrus, a peak in circulating estradiol, derived from the
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developing ovulatory follicle on the ovary, triggers a surge of gonadotropin-releasing hormone
(GnRH) from the hypothalamus. Subsequently, a pre-ovulatory surge of luteinizing hormone
(LH) and follicle-stimulating hormone (FSH) is released from the anterior pituitary
(Schoenemann et al., 1985; Turzillo & Nett, 1999). The pre-ovulatory LH surge targets the
Graafian (dominant) follicle and initiates the process of ovulation: follicular edema and
weakening of the follicular extracellular matrix. The resulting increase in pressure on the
weakened follicular wall leads to a rupture of the pre-ovulatory follicle. The antral contents,
including the oocyte are captured by the fimbriae of the infundibulum of the oviduct.
Metestrus
Metestrus begins following ovulation and is defined as days 1-5 of the EC. A small
amount of uterine-derived blood can be observed exiting the vulva (metestrus bleeding) and
residual vaginal mucus are often observed during this stage of the EC (Bane & Rajakoski, 1961;
Weber et al., 1948).
The LH surge responsible for ovulation also initiates differentiation and re-organization
of the theca, granulosa, endothelial, fibroblast, and immune cells of the ovulatory follicle. These
cells will collectively form the CL. The development of the CL occurs during metestrus, wherein
the gland rapidly gains the capacity to produce and secrete the sex steroid hormone progesterone.
Progesterone is essential for the maintenance and establishment of pregnancy in the event the
released ovum becomes fertilized.
During metestrus, GnRH, LH and FSH are released in a tonic release pattern (low
amplitude and frequency of secretions). The secretion pattern allows for sufficient luteotropic
(pro-CL survival) signal, thereby promoting normal CL function—namely steroidogenesis
(Donaldson & Hansel, 1965; Summons & Hansel, 1964).
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Diestrus
Diestrus is defined as days 6-17 of the EC. During this phase of the cycle, metestrus
bleeding ceases, and hyperplasia and hypertrophy of the CL begins to plateau as the gland
reaches full maturity.
Maximal production of progesterone is achieved by day 7-10 of the EC and is maintained
until the end of diestrus, or late into pregnancy. Negative feedback of progesterone on the
hypothalamus and anterior pituitary results in continued tonic secretion of LH and FSH during
diestrus. However, pulses of LH shift to a low frequency/high amplitude pattern due to this
negative feedback. This pulse pattern is essential to maintain progesterone production by the
diestrus CL.
Proestrus
Proestrus is defined as approximately days 17-24 of the EC. Around day 17 of the EC,
the lack of a maternally recognized pregnancy leads to pulsatile endometrial secretions of
prostaglandin F2 alpha (PGF2𝛼) from the uterus (Fortier et al., 1988). PGF2𝛼 synthesis and
secretion initiates when luteal progesterone output is reduced as an outcome of progesterone
receptor downregulation within the hypothalamus and endometrium. As a result, the
progesterone block on uterine and follicular estradiol synthesis and secretion is removed
(McCracken et al., 1999). The elevation in circulating estradiol, from the dominant follicle,
induces increased expression of estrogen receptor alpha and subsequent transcriptional regulation
in uterine epithelial cells (Bartol et al., 1981; Louis et al., 1977; Meyer et al., 1988; Roberts et
al., 1976). Oxytocin G-protein receptor numbers increase due to the action of estradiol on uterine
epithelial. Oxytocin, from the posterior pituitary, binds to its receptor leading to the activation of
a complex intracellular signaling pathway allowing for the increase in activity of cytosolic
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phospholipase A2. Once activated, phospholipase A2 cleaves arachidonic acid from the sn-2
position of membrane glycerophospholipids. Prostaglandin H2 synthase converts the free
arachidonic acid to PGH2. The culmination of cell death and changes in the microenvironment
of the CL during luteal regression reduces luteal progesterone output such that the hypothalamic
surge of GnRH is no longer inhibited. Removal of the negative GnRH feedback generates
sufficient FSH for the selection of secondary and eventually dominant follicle. The estrous cycle
will then recommence as the dominating follicle produces adequate estradiol to induce the
GnRH/LH surge required for ovulation, as previously mentioned. Proestrus can also be induced
via administration of exogenous PGF2α after day 4 of the estrous cycle, which is commonly
used for estrus synchronization (Inskeep, 1973; Odde, 1990).
Pregnancy
In the event the ovum does become fertilized, the estrus cycle will only be halted if the
developing conceptus (embryo and associated extra-embryonic structures) successfully initiates a
maternal recognition of pregnancy (MRP). The initiation of an MRP is triggered by
trophoblastic-derived interferon tau (IFN𝜏; previously termed trophoblastic protein-1) secretion
between days 16-24 post fertilization (Roberts et al., 1992). IFN𝜏 inhibits estrogen receptor
expression and oxytocin binding to endometrial epithelial cells, thereby blocking the pulsatile
oxytocin-PGF2𝛼 cascade that would otherwise induce luteolysis (Arosh et al., 2004; Helmer et
al., 1989; Mirando et al., 1993; Spencer et al., 1995). As a result, the CL is maintained and the
progesterone secretion is continued, therein allowing for the establishment and further
maintenance of the pregnancy. The luteal derived progesterone specifically targets the uterus,
effectively aiding in implantation and embryonic support both directly, and indirectly through
stimulation of histotrophic secretions—a culmination of ions and nutrients (Clemente et al.,
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2009; Spencer et al., 2006). IFN𝜏 may also support pregnancy via maternal immune cell
modulation (Hansen et al., 2010).
Pregnancy Loss
Pregnancy loss in the beef cattle industry continues to be problematic, wherein only 46%
of artificial inseminations will result in a successful pregnancy (Reese et al., 2020). A report
from the Organisation for Economic Co-operation and Development and the Food and
Agricultural Organization (OECD/FAO) predicted that global beef and veal consumption will
continue to rise (albeit at a slower rate compared to previous years) world-wide, predominantly
in developing nations such as sub-Saharan Africa (2021). Therefore, increasing pregnancy rates
is crucial to sustain demand. Moreover, improving pregnancy rates by just one percent equates to
a 291-million-dollar economic boon to the industry (Davis & White, 2020). Additionally,
findings derived from the pursuit of improved fertility and reproductive health in cattle have
already provided key insights into human, female reproductive health (Langbeen et al., 2015;
Malhi et al., 2005). As such, it is plausible that the resulting scientific findings from the pursuit
of pregnancy interventions in cattle may further contribute to women’s reproductive health.
Most pregnancy loss occurs in the first month of gestation, as reported in a recent metaanalysis (Reese et al., 2020). Within the first month of pregnancy, most pregnancy loss occurs
before day 7 following fertilization (28.4%), followed by days 16-32 (15.6%; the critical window
for a successful MRP), and finally days 7-16 (3.9%). Depending on the breeding method (natural
vs artificial insemination), causes for the cessation of pregnancy vary and are specific to the time
of gestation (Bellows & Short, 2021; Farin et al., 2006; Moore et al., 2021; Pope, 1988).
However, independent of the breeding method utilized, within the vulnerable first 100 days of
gestation (average 283-day gestational period) many critical biological processes must be
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executed by the fetus and maternal environment, therein providing sources for potential failure.
For example, one theorized cause for pregnancy loss between day 16-32 of gestation is due to a
slower developing conceptus. Clearly, progesterone regulates development of the early
conceptus and as such, a delay in initial progesterone secretion by the early CL leads to a slowerdeveloping conceptus. As a result, the slower developing, albeit viable, conceptus may not
secrete sufficient IFN𝜏 to successfully establish an MRP (Godkin et al., 1997; Lafrance et al.,
1989; Mann & Lamming, 2001; figure 1.2). Consequentially, the uterine-PGF2𝛼 release is no
longer suppressed, resulting in luteolysis (luteal regression) and subsequent pregnancy loss
(figure 1.2). Multiple interventions have been explored to inhibit the pulsatile secretions of
PGF2𝛼, namely the administration of IFN𝜏 or PGF2𝛼 synthase inhibitors. However, these
methods prove as only partially effective, are inefficient and labor intensive for long-term usage,
are highly debated with regards to pregnancy success rates, or only prove beneficial for
particularly agitated or abnormally presenting cattle (Besbaci et al., 2021; Geary et al., 2010;
Jaśkowski et al., 2021; Karasahin et al., 2021; Merrill et al., 2007; Meyer et al., 1996; Purcell et
al., 2005). Therefore, additional interventions and approaches for increasing pregnancy rates are
warranted. One approach, which we explore later in more detail, may be reducing luteal
sensitivity to PGF2α with use of fish meal dietary supplementation. In doing so, the slower
developing conceptus would have a larger window of time to establish an MRP, and sufficiently
inhibit PGF2α; therein improving pregnancy rates during days 16-32 of gestation.
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Figure 1.2
Maternal Recognition of Pregnancy in a Normal vs Slow Developing Conceptus

Note. A) A normally developing conceptus, shown as a filamentous structure, secretes sufficient
interferon-tau (IFN𝜏) to establish a successful cross talk, and an eventual maternal recognition of
pregnancy. The secreted IFN𝜏 effectively inhibits prostaglandin F2 alpha (PGF2α) release from
the uterus, therein preserving the lifespan of the corpus luteum (CL). The CL will then continue
to secrete progesterone, therein supporting the developing conceptus. B) A slow developing
conceptus, shown as an oval-like structure, does not secrete sufficient IFN𝜏, therein allowing for
PGF2α release from the uterus. The secreted PGF2α will then induce luteal regression, and
prematurely terminate the pregnancy.
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The Corpus Luteum
The term corpus luteum (Latin translation: bodies yellow) was coined by Marcello
Malpighi in the early 1600s and further delineated by Regnier de Graaf in the late 1600s
(Niswender et al., 2000). As previously described in brief, the CL is an ephemeral gland that is
essential for the establishment and maintenance of pregnancy, the function of which was first
established in rabbits in the early 1900s (Fraenkel & Cohn, 1901; Magnus, 1901). Following
ovulation, the corpus luteum will swiftly develop from the remnants of the ovulatory follicle, and
begin its primary function, the production of the sex steroid hormone progesterone. The
influence of progesterone is multifactorial; the steroid acts as a luteotropic and pro-survival
signal for the gland itself via paracrine signaling (Liszewska et al., 2005; Rekawiecki &
Kotwica, 2007; Rekawiecki et al., 2005). The CL lifespan encompasses the luteal phase of the
estrous cycle and can further be subdivided into four distinct stages: early, middle, late, and
regressing CL. As the gland progresses through these luteal stages, considerable change occurs
within the glandular microenvironment, vascularization and blood flow, cell types and
phenotypes, immunological responses and regulation, and gross anatomy.
Early-Stage Corpus Luteum: Day
1-4 of the Estrous Cycle
The development of the early-stage CL begins following ovulation and is defined as day
1-4 of the EC (Ireland et al., 1980). The early-stage CL undergoes significant growth and
neovascularization, along with extensive cellular infiltration and differentiation.
Gross Anatomy
As a result of the elevated mitogenic and neovascularization factors, luteal cell
differentiation and steroidogenesis, and rapid tissue construction and remodeling, the gland
undergoes a doubling time of 65 hrs; a trophic rate comparable only to the fastest-growing
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tumors (Reynolds & Redmer, 1999). On day 4 of the EC, the glandular mass averages 0.95 g
(Reynolds et al., 1994). The gross anatomy of the early CL is as follows: red exterior, nonepithelialized point of ovulation (i.e., where the crown will develop following epithelialization),
cells are disorganized and loosely assembled, red/white interior, may contain a blood clot
(name’s sake of corpus hemorrhagicum, an early luteal structure), avascular, 0.5-1.5 cm in
diameter, and the ovary surrounding the CL will have no follicles larger than 10 mm in diameter
(Ireland et al., 1980). Vascularization and Blood Flow
The early CL develops in a hypoxic environment, due to localized hemorrhaging
resulting in reduced efficiency of gas exchange, decreased ovarian blood flow in the periovulatory period, and lack of established vasculature supplying the readily dividing cells (Wise
et al., 1982). Although oxygen perfusion to the developing CL has not been established, hypoxiainducible factor 1 is highly expressed in the early developing CL (Nishimura & Okuda, 2010).
The hypoxic environment is essential for the formation of new (vasculogenesis), and extension
of previous (angiogenesis), vasculature to the differentiating gland (Nishimura & Okuda, 2010).
Directly before ovulation, and (or) following the LH surge, mass neovascularization
(angiogenesis and vasculogenesis) occurs in the ruptured follicle due to the potent angiogenic
and mitogenic gene and protein expression; fibroblast growth factor and receptor, vascular
endothelial growth factor (VEGFA), VEGFA receptors (VEGFR), matrix metalloproteinases,
and tissue plasmogen activator (Berisha et al., 2000, 2006, 2008; Robinson et al., 2007; Woad &
Robinson, 2016). Woad and Robinson (2016) review a more comprehensive list of the reported
elevated neovascularization factors. Some anti-angiogenic factors are prevalent during luteal
development, though most likely play a role in the optimization and remodeling of the
vasculature (Woad & Robinson, 2016). Cells associated with the vasculature (endothelial cells,
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pericytes, and vascular smooth muscle cells) account for 85% of all cellular divisions in the early
CL (Reynolds & Redmer, 1999). The increase in matrix metalloproteinase (a result of the LH
surge) results in degradation of the follicular basement membrane allowing for the migration of
endothelial cells and pericytes into the developing CL. The number of capillaries per crosssectional area of the CL is the largest in an early and middle-stage CL (Hünigen et al., 2008). As
a result of the metabolic demands from the extensive remodeling, most of the blood flow to the
CL-bearing ovary is allocated to the CL, as demonstrated in sheep (Niswender et al., 1976).
Major blood supply to the CL-containing ovary comes from the ovarian artery and the ipsilateral
uterine artery (Ford & Chenault, 1981). In cattle, by day 4 of the EC, the area of blood flow to
the CL already comprises 15% of the gland, which is comparable to a middle-cycle CL (Acosta
et al., 2002).
Cellular Composition
Concurrent with the rapid neovascularization, the two predominant steroidogenic cell
types of the ovulated follicle, theca and granulosa, undergo LH-stimulated differentiation
(luteinization) into small and large luteal cells, respectively. In the dominant follicle, the theca
and granulosa cells primarily produced androgens and estradiol, respectively, from unesterified
cholesterol, the precursor to all steroid hormones. However, following luteinization, aromatase
activity in granulosa cells is inhibited, therein preventing estradiol synthesis (LaVoie, 2016).
Additionally, the LH surge further increases mRNA expression and activation of enzymes
involved in progesterone synthesis, namely, steroidogenic acute regulatory protein (STAR;
encoded from STARD1), cholesterol side-chain cleavage enzyme (P450scc; encoded from
CYP11A1), and 3-beta-hydroxysteroid dehydrogenase (3β-HSD; encoded from 3β-HSD) as
reviewed by King and LaVoie, (2012). Finally, during luteinization, the large luteal cells gain the
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ability to synthesize an abundance of progesterone, de-novo, and the small luteal cells maintain
their ability to do so from their thecal origin (LaVoie, 2016). Another cell type in the early-stage
CL includes fibroblasts, which infiltrate the developing CL and aid in the establishment of the
gland (Melmed et al., 2015).
Progesterone Output
Progesterone synthesis and secretion from the large and small luteal cells begin as early
as day 1 of the EC, and steadily increases into the next stage of the CL; the middle phase CL
(Robinson et al., 2005). By day 4 of the EC, the average blood progesterone concentration
reaches 1 ug/g in luteal tissue and 0.6 ng/ml in serum (Tsai & Wiltbank, 1998).
Immunological Regulation
Immune cells play a significant role in early luteal function. Following the LH surge,
immune cells begin to infiltrate the ovary and follicular region due to elevated chemokine
secretions and elevated expression of immune cell-attracting ligands (adhesion molecules and
selectins) on endothelial cells (Rohm et al., 2002; Walusimbi & Pate, 2013). A study
demonstrated that in mice, F4/80+ macrophages infiltrate from the bone marrow during luteal
development (Kizuka et al., 2012). Moreover, in rats, CD11b/c+ macrophages and CD3+
lymphocytes infiltrate from the spleen (Oakley et al., 2010). An elevated presence of interleukin
8 (IL-8; a neutrophil chemoattractant and pro-angiogenic cytokine) accounts for the prevalence
of polymorphonuclear neutrophils in the early (1-4 of the EC) CL (Jiemtaweeboon et al., 2011).
In vitro studies demonstrated that IL-8 promotes luteal-derived endothelial cell proliferation and
augments progesterone output in luteinized granulosa cells, indicating a potential role of the
cytokine in angiogenesis and steroidogenesis during luteal development (Shimizu et al., 2012).
In the developing bovine CL, T cell populations are nearly undetectable, and begin to increase
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only once the gland is established in the middle CL phase (Bauer et al., 2001). The role of T cells
in luteal development is not well established, though in certain species (no evidence in bovine),
T lymphocytes increased progesterone production in granulosa-luteinized cells—indicating a
potential role in steroidogenesis later in development (Walusimbi & Pate, 2013). Furthermore,
macrophage-monocytes, eosinophils, and MHC II expression are all elevated in the early CL on
day 1-5 of the EC (Penny et al., 1999; Reibiger & Spanel-Borowski, 2000). Macrophages are
theorized to transition to an M2- type macrophage in the developing CL, in addition to N2- type
neutrophils—both of which are typically located in wound healing and tissue repair
environments, thereby aiding in the process of angiogenesis, and are indicative of a more antiinflammatory environment (Shirasuna & Miyamoto, 2016). The precise role eosinophils play in
the early CL is not entirely clear, though evidence suggests a potential role in supporting
steroidogenesis, as inhibition of eosinophil infiltration reduced progesterone output (Kliem et al.,
2013). Additionally, regulatory cytokines (secreted by local leukocytes and luteal cells) such as
tumor necrosis factor-alpha (TNF𝛼), interferon-gamma IFN𝛾), and interleukin-1 beta (Il-1𝛽) are
all expressed in the early CL, along with later luteal stages (Petroff et al., 1999; Sakumoto et al.,
2000; Terranova & Rice, 1997). Pate et al. (2010) and Shirasuna and Miyamoto (2016) further
explore cytokines and their roles in the early CL. While it is apparent immune regulation is
heavily intertwined with the process of neovascularization, much is to be explored.
Middle Stage Corpus Luteum:
Day 5-12 of the Estrous
Cycle
The middle stage CL is defined as day 5-12 of the EC and is a transitionary phase
wherein luteal blood supply plateaus (despite continuous angiogenesis), cellular infiltration and
cellular differentiation begin to slow, and cellular trophy and steroidogenesis become the
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primary functions. Additionally, the proliferation of all luteal-located cells decreases, except for
cells associated with vascularization, which continue to increase.
Gross Anatomy
On day 8 of the EC, the gland averages 3.41 g (Reynolds et al., 1994). The gross anatomy
of the middle CL is as follows: the point of rupture (crown) is fully epithelialized, is red or
brown in color both internally and externally while the body of the gland is orange, vasculature
mostly encompasses the periphery of the gland, the CL diameter ranges from 1.6-2 cm, and
ovarian follicles greater than 10 mm in diameter will be present (Ireland et al., 1980).
Vasculature and Blood Flow
From day 1-12 of the EC, the CL vasculature increases roughly seven-fold, despite a lack
of significant change in the total area of glandular blood flow from day 4 of the EC (Acosta et
al., 2002). The absence of a quantified change in luteal blood flow, despite rapidly increasing
progesterone levels, and increasing abundance of arterioles may be because Doppler
ultrasonography is not sensitive enough to pick up changes in capillary blood flow, as evident by
pseudo coloration only displayed on the periphery of the gland, despite the extensive intra luteal
capillary network in the middle CL (Hünigen et al., 2008). The number of capillaries per crosssectional area of the CL is largest in a mature CL on day 8-17 EC (Hünigen et al., 2008).
Additionally, extensive angiogenesis continues in the middle CL stage, as evident by the
elevated rate of apoptosis in middle CL endothelial cells (Hünigen et al., 2008).
Cellular Composition
While the glandular vascularization continues to expand, by the end of the middle
(entering the late phase) luteal phase, luteal cell composition establishes a ratio of 4% large luteal
cells (38 um diameter), 27% small luteal cells (17 um diameter), 53% endothelial cells and
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pericytes (11 um diameter), 6% fibroblasts (15 um diameter) and 2% immune cells (O’shea et
al., 1989). The remaining 8% of space is allocated to vessel lumens and intracellular space.
While large luteal cells make up the smallest proportion of total glandular cells, their large size
occupies 40% of the volume, and small luteal cells occupy 28% of the volume. In the middle CL,
luteal cells increase LH (predominantly in small luteal cells) and non-LH (predominantly in large
luteal cells) stimulated progesterone output, and large luteal cells continue to increase in size
(Robinson et al., 2006). A genome-wide mRNA expression analysis uncovered potential roles of
small and large luteal cells branching beyond the classical function of steroidogenesis,
effectively underlining the necessity for exploring the physiology of luteal cells in addition to
steroidogenesis (Baddela et al., 2018). Notably in small luteal cells, genes associated with
extracellular matrix construction and recruitment of immune cells were elevated, whereas, in
large luteal cells, mitochondrial metabolism and luteal regression associate pathways were
elevated.
Progesterone Output
Progesterone output reaches heightened concentrations on day 7-12 of the EC (4 ng/ml
serum; day 11 of the EC), which is equivalent to 3.41x1017 molecules of progesterone per minute
in the average middle CL (Robinson et al., 2005; Tsai & Wiltbank, 1998). Progesterone output
from the corpus luteum is required to maintain pregnancy for the first 215 days of gestation,
wherein the placenta and adrenal glands will take over progesterone synthesis, or until luteal
regression (Wendorf et al., 1983).
Immunological Regulation
The immune phenotype continues to shift in the middle CL compared to the early CL.
Both macrophage and monocyte populations are elevated in the middle CL when compared to

16
early CL—and do not significantly differ in a late CL (Townson et al., 2002). The T lymphocyte
population is comprised of 25% CD4+ T helper cells, 45% CD8+ cytotoxic T cells, and 30%
gamma delta T cells. Of the three T cell types, the gamma delta T cell population was the only
one activated in cell culture by middle-stage CL, though their role in tissue management is
unclear, as both IFN𝛾 and interleukin 10 (apposing pro- and anti-inflammatory molecules,
respectively) were secreted (Davis & Pate, 2007). However, more recently, gamma delta T cells
are proposed to be regulatory in the middle CL, as only IL-10 mRNA was present in middle
phase luteal cells, and IFN𝛾 was downregulated (Walusimbi & Pate, 2014). The immune
phenotype of a middle CL is theorized to be regulatory, due to the loss of regulatory cells during
luteal regression (Poole & Pate., 2009). Additionally, progesterone has been postulated to play
an immunosuppressive role in the middle CL, due to the presence of progesterone receptors in
luteal T cells (Ndiaye et al., 2012). Messenger RNA transcripts for select cytokines and their
receptors (TNF𝛼, TNFR1, TNFR2, IFN𝛾) are all present, though are non-differentially expressed
when compared to other CL stages (Petroff et al., 1999; Sakumoto et al., 2011). The role of IFN𝛾
and TNF𝛼 in the middle CL has not been made apparent, as the middle CL is generally regarded
as an anti-inflammatory environment once established.
Late-Stage Corpus Luteum: Day
13-17 of the Estrous Cycle
The late CL is defined here as day 13-17 of the EC. The late luteal stage is a determining
phase for the CL, as life or death depends on the success of the MRP, as previously discussed.
While the fate of the gland teeters, minimal documented changes occur in the vasculature and
blood flow from the middle to the late luteal stage (save for gross vesicle organization) or
changes to luteal cell types and steroidogenic capacity, and so will not be discussed as different
from the middle stage CL.
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Gross Anatomy
On day 14 of the EC, the gland averages 4.45 g, therein reaching the maximal mass
(Reynolds et al., 1994). The gross anatomy of the late CL is as follows: the crown of the gland is
epithelialized, external color is tan or orange, internal color is orange, diameter ranges from 1.6-2
cm (consistent with the middle CL), vasculature jackets the crown while maintaining the
peripheral arterioles observed in the middle CL, and follicles larger than 10 mm in diameter may
or may not be present (Ireland et al., 1980).
Immunological Regulation
Within late CL, CD5+ B-cells (which are prevalent during all luteal stages) were reported
as the most prevalent immune cell, followed by monocyte and macrophage (Penny et al., 1999).
The latter two cell types do not significantly differ from middle-stage CL but do from early CL
but the CD5+ B-cells nearly triple in abundance in the late CL (Penny et al., 1999; Townson et
al., 2002). Protein expression for the cytokine TNF𝛼 is highest during this stage, yet TNFR1
receptor mRNA expression is at its lowest or is unchanged relative to the early and middle CL
(Friedman et al., 2000; Sakumoto et al., 2000). Interestingly, subsets of luteal cells begin to
express class II MHC markers during the late-stage CL, which is conversely dampened by
pregnancy or a pregnancy-like environment (Benyo et al., 1991; Pate, 1995; Penny et al., 1999).
Although class II MHC markers are typically reserved for professional antigen-presenting cells
(i.e., B-cells, Macrophages, dendritic cells), the presence of luteal cells may indicate a
mechanism enhancing the specificity of the T cell response required for luteal regression (Pate et
al., 2010; Petroff et al., 1997).
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Regressing Corpus Luteum: Day
18-21 of the Estrous Cycle
Luteal regression is temporally defined as day 18 up until day 24 of the EC. In the event
of an unsuccessful MRP, the corpus luteum will be targeted for regression, commencing with
uterine PGF2𝛼 release delivered to the CL via the uterine vein and artery countercurrent
network. The mechanisms by which PGF2𝛼 is released from the uterus have previously been
discussed. How PGF2𝛼 influences luteolysis will be reviewed in this section.
Gross Anatomy
On day 18 of the EC, the gland averages 4.12 g and will continuously decrease in mass
until the formation of the fibrous corpus albicans (Reynolds et al., 1994). The gross anatomy of
the regressing CL includes epithelization of the crown, light yellow to white external, orange to
yellow internal pigment, avascular, less than 1 cm in diameter (and progressively decreasing),
and follicles larger than 10 mm in diameter will be present on the ovary (Ireland et al., 1980).
Structural vs Functional Regression
Luteal regression is further analyzed with respect to functional or structural regression.
Functional regression precedes structural regression and consists of a rapid decrease in serum
progesterone below 1 ng/ml, without evidence of rebounding. In cattle, serum progesterone
decreases as early as four hrs following exogenous PGF2𝛼 exposure (Tsai & Wiltbank, 1998).
Gene and protein expression for molecules involved in steroidogeneses such as STARD1/STAR
and 3β-HSD are reduced during luteal regression and most likely contribute, in part, to the loss
of steroidogenic capacity (Juengel et al., 1998; Pescador et al., 1996). Moreover, structural
regression defines the loss in cellular viability and subsequent decline in glandular mass. The CL
may begin to structurally regress as early as 8 hrs following exposure to exogenous PGF2𝛼
(Acosta et al., 2002), and will continue to do so for multiple days, well into the following estrous
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cycle. Only a white scar (corpus albicans) will remain as an indication of the gland’s once-lived
glory.
Prostaglandin F2 Alpha: The
Endogenous Luteolysin
It has been well established that PGF2𝛼 is the luteolytic agent in ruminants, as reviewed
by Meidan et al. (2016) and Bishop et al. (2022). However, the processes occurring between
uterine-PGF2𝛼 release and luteal regression are continuously being investigated. Despite PGF2𝛼
receptor expression on small and large luteal cells and endothelial cells, the cellular outcomes of
ligand-receptor binding are far more convoluted than just direct inhibition of steroidogenesis and
cell death (Mamluk et al., 1998). For example, in vitro culture of luteal cells exposed to PGF2𝛼
generates contradictory results depending on the composition of the culture. Some studies
demonstrated reduced progesterone output and cell viability following PGF2𝛼 exposure, as was
expected given the luteolytic capabilities of PGF2𝛼, and yet other laboratories report an increase
in progesterone output and cell viability, as reviewed by Meidan et al. (2016). Some laboratories
report that by co-culturing endothelial cells, steroidogenic luteal cells, and immune cells, the
expected progesterone knockdown was observed (Girsh et al., 1995; Korzekwa et al., 2008). As
a result of such findings, it was theorized that PGF2𝛼, in the appropriate microenvironment,
illicit changes in gene expression and cellular outputs (i.e., elevated secretion of proinflammatory cytokines) that in turn alter steroidogenesis and cellular viability (Meidan et al.,
2016). In other words, PGF2𝛼 is merely an initiator of luteal regression, by which the complete
abrogation of the gland would not be possible without the collective changes in all luteal cell
types. This is concurrent with other theories, outlined and summarized by Talbott et al. (2017),
suggesting that PGF2𝛼 activates a cascade of alterations in CL gene expression, changes in
immune cell phenotypes, and cytokine expression and release, resulting in a knockdown in
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steroidogenesis and mass cellular death; all events culminating in luteal demise. In addition, a
PGF2𝛼-induced rapid decline in luteal blood flow and loss of vascularization is a well-supported
contributor to luteal regression (Nett et al., 1976). Despite some aspects of luteal regression
being well-defined and robustly supported by independent works, the true order and complexity
of proceedings remains obscure due to the assumed complexity of the event.
Changes in Vasculature and Blood
Flow
Alterations in luteal vasculature and blood flow collectively represent key physiological
changes that occur during regression. During early luteal regression (day 18-21 of the EC), all
cell types undergo similar rates of apoptosis until late regression (day 22-24 of the EC), wherein
luteal cells are targeted for cell death more rapidly and robustly than the vasculature (Hünigen et
al., 2008). The rate of apoptotic endothelial and luteal cells is highest in a regressing CL
(Hünigen et al., 2008). During luteolysis in other species, VEGFA and VEGFR are reduced
(Fraser et al., 2005). However, Hünigen et al. (2008) demonstrated that VEGFA and VEGFR
were elevated in smooth muscle cells in a late-regressing CL; aligning with a previous finding
that a late-regressing CL is predominantly composed of endothelial networks. Additionally,
angiotensin 2, which plays a role in vasculature destabilization, was elevated during early
regression (Hünigen et al., 2008; Yancopoulos et al., 2000). In accompaniment to the changes in
vasculature, alterations in luteal blood flow similarly occur. Following both induced and natural
luteolysis, the percentage of luteal blood flow (percent of luteal area) doubles 30 mins following
exogenous PGF2𝛼 exposure, or during the time of natural uterine-PGF2𝛼 release on day 16-17
of the EC (Acosta et al., 2002; Miyamoto et al., 2005). The area of luteal blood flow then drops
steadily after the acute surge until the time of regression (Acosta et al., 2002; Miyamoto et al.,
2005). Additionally, the time-averaged maximum velocity of a main luteal artery did not
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increase, and instead steadily decreased over 24 hrs (Acosta et al., 2002). Furthermore, in sheep,
decreased ovarian blood flow coupled with CL-arterial shunting and decreased vasculature
occurs during induced and natural luteolysis (Niswender et al., 1976).
While much remains to be explored, some mechanisms and molecules involved in the
vascular control of the regressing gland have been identified in ruminants. Endothelial nitric
oxide synthase and inducible nitric oxide synthase, both enzymes that synthesize the potent
vasodilator nitric oxide, are elevated in luteal tissue during the late CL stage and early luteal
regression (Skarzynski et al., 2003a). Inhibition of nitric oxide synthase inhibited the luteolytic
capacity of PGF2𝛼, indicating the importance of nitric oxide in luteolysis (Skarzynski et al.,
2003b). Interestingly, a middle CL exposed to nitric oxide undergoes a very similar acute
increase in luteal blood flow (percent area of blood flow) followed by a dramatic decline, as
observed following PGF2𝛼 administration (Shirasuna et al., 2008). Shirasuna et al. also
demonstrated that administration of NO lead to functional luteolysis just over an hour following
exposure (2008). A review by Miyamoto et al. (2005) summarized that mRNA transcripts and
proteins of potent vasoconstrictive factors and respective receptors (endothelin-1, endothelin
type B receptor, angiotensin-converting enzyme, and angiotensin II) were all elevated at different
time points within 0.5-24 hrs following PGF2𝛼 administration. Findings were similar in cows
with a naturally regressing CL (Miyamoto et al., 2005). Additional mechanisms by which
PGF2𝛼 may induce changes in luteal blood flow include the early degradation of capillaries and
endothelial cells during the time of luteolysis. How and why the CL would undergo an acute
increase in blood flow, when destabilization of the vasculature has already begun, remains
unclear. It is worth noting that while Doppler ultrasonography remains a powerful tool, it may
not have the capacity to detect small changes in centrally located capillaries, as no group has
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visually displayed central glandular blood flow to the expect degree given capillary density. It
therefore remains plausible that blood flow is not maintained at the level of the central capillaries
due to capillary destabilization. Evidently, much is to be explored. Taken together, elevated
nitric oxide may be the cause for the acute increase in luteal blood flow, followed by elevation in
vasoconstrictive factors and cell death in vasculature cells that collaboratively reduce glandular
blood flow.
An additional theory involves a pooling effect, where PGF2𝛼 initially acts as a
vasoconstrictor, therein clamping off blood supply to the gland and displaying an apparent
increase in blood flow, as per the increase in the percentage of luteal blood flow following
PGF2𝛼 exposure (Acosta et al., 2002). Such an event may expedite a pro-inflammatory and prodeath environment required for regression, as does occur in any tissue deprived of blood
profusion (i.e., ischemic events). This theory is based upon two notions: 1) PGF2𝛼 in other
systems is a known vasoconstrictor and 2) timed average flow velocity of main luteal arteries
steadily decreases following administration of PGF2𝛼, despite an increase in percentage area of
luteal blood flow (Still & Greiss, 1978; Yamamoto et al., 1972). However, this discrepancy in
timed average flow velocity could be due to vasodilation (nitric oxide induce) and increased
profusion. Regardless of the mechanism at play, the reduction in glandular blood flow may be
limiting the supply of cholesterol to the CL, therein reducing glandular capacity for progesterone
synthesis, as cholesterol is primarily supplied to luteal cells through the blood. Additionally, the
loss or reduction of nutrient and gas exchange to any tissue causes extreme cellular stress, therein
amplifying the pro-death environment of regression. We propose that the maintenance of luteal
blood following exposure to low-dose intra-uterine infusions of PGF2𝛼 may be a mechanism by
which the CL remains resistant to the induction of luteal regression. Although the reduction in

23
blood flow to an early-developing CL does not influence progesterone output, the degree and
speed by which blood flow declines during regression may be more harmful to cells and the
process of steroidogenesis (Robinson et al., 2006). Additionally, a reduction in luteal blood flow
is always accompanied by a reduction in blood progesterone in regressing CLs, though whether
that is a result of loss in blood flow versus repression of steroidogenesis by the changing luteal
environment (or both) has yet to be defined (Ford & Chenault, 1981).
Immunological Regulation
During both natural and induced luteolysis, immune cell infiltration begins as early as
five mins post-infusion with the predominate cell types being neutrophils and macrophages
(Penny et al., 1999; Shirasuna et al., 2012; Townson et al., 2002). P-selectin activity is enhanced
following exposure to PGF2𝛼 in endothelial cells, indicating increased capability for leukocyte
attachment and eventual diapedesis during luteal regression (Mamluk et al., 1998). Broadly,
leukocyte proliferation increases 3.5-fold (20%-70%) from a middle to regressing CL (Bauer et
al., 2001). The immune profile also shifts during early regression, leading to a significant
increase in CD2+ T cells and natural killer cells, CD8+ cytotoxic T-cells, CD5+ B cells, CD4+
helper T cells CD14+ monocytes and macrophages cells (Bauer et al., 2001; Penny et al., 1999;
Smith & Meidan, 2014; Townson et al., 2002). During late regression, the previously mentioned
cell types increase in abundance, as well as CD3+ T cells, and CD18+ leukocytes; all of which are
present in a pro-inflammatory tissue phenotype (Penny et al., 1999). In culture, luteal cells
previously exposed to PGF2𝛼 elicit greater T cell proliferation than those not exposed to PGF2𝛼
(Cannon & Pate., 2003). However, multiple research groups have found no change in either
CD8+ cytotoxic T cells or CD4+ helper T cells during regression (Penny et al., 1999; Townson et
al., 2002). The regulatory T cell marker, Foxp3, is downregulated during regression, along with a
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shift in gamma delta T cells from WC1- (pro-regulatory) to WC1+ (pro-inflammatory) (Cannon
& Pate, 2003; Hedges et al., 2003; Meissner et al., 2003; Walusimbi & Pate, 2014). Additionally,
populations of luteal cells express class II MHC molecules during regression, which like the latestage CL, may be an attempt to amplify the T cell response (Benyo et al., 1991; Petroff et al.,
1997). Changes in cytokine expression also represent a pro-inflammatory environment during
regression (Talbott et al., 2017). Expression of monocyte chemoattractant protein-1 mRNA,
which is known to play a role in monocyte, macrophage, and T lymphocyte recruitment, was
highest during regression when compared to an early CL (Kliem et al., 2009; Townson et al.,
2002). Expression of TNF𝛼 protein was greatest in the regressing CL, following the drop in
progesterone output (Shaw & Britt, 1995). Additionally, following induced regression,
TNF𝛼,TNFR1, IL-1𝛽, IFN𝛾, and interleukin 8 mRNA transcripts were all elevated (Friedman et
al., 2000; Jiemtaweeboon et al., 2011; Neuvians et al., 2004). Pate et al. propose that immune
cells may have one of two roles during luteal regression (Pate et al., 2012; Pate & Keyes, 2001).
The first hypothesis, and the more generally supported hypothesis in the literature, proposes that
immune cells and cytokines aid in the reduction of steroidogenesis and promote cell death,
therein propagating luteal demise. The second hypothesis states that immune cells have a
regulatory role to ensure the remaining luteal cells are continuously supported and nurtured until
induction of death. A third hypothesis would entail both proposed mechanisms, wherein a
population of immune cells propagate cell death, while another regulates the degree of the
inflammatory event to ensure a timely resolution.
Types of Programmed Cell Death
Extensive cellular death occurs during luteal regression, as previously discussed. The
most abundantly reported form of programmed cell death during luteal regression includes
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apoptosis. Apoptosis signaling can occur through two primary routes: internal and (or) external,
both of which are caspase-dependent mechanisms (Cohen, 1997). When the intracellular
environment is no longer optimal for cell survival (i.e., unrepairable DNA damage or hypoxia)
the intrinsic apoptotic pathway will be activated. In the event of DNA damage, stabilization of
the tumour suppressive protein P53 activates BCL2 Associated X (BAX) and other pro-apoptotic
factors that propagate cytochrome C release from the mitochondria. B-cell lymphoma 2 (BCL-2)
is typically present in a pro-survival cell, inhibiting cytochrome C release, but is overridden and
suppressed by prominent upstream apoptotic signals. Cytochrome C, apoptotic peptidase
activating factor 1 (apaf-1) and caspase 8 (Casp8) together form the apoptosome, which cleaves
the effector caspase 3 (Casp3). Caspase 3 then actuates caspase-activated DNase (CAD), which
in turn fragments DNA, a hallmark of apoptosis. The extrinsic apoptotic pathway occurs when
the extracellular environment of a cell targets it for cellular death. The pathway begins when a
peripheral cell (commonly a killer lymphocyte) binds an FS-7-associated surface (FAS) antigen
to the FAS ligand (FAS L) on the recipient cell. The binding event recruits a FAS-associated
death domain (FADD) which recruits and activates caspase 8, which in turn galvanizes the
executor caspases (Casp3, 6 and 7). A similar series of events can occur upon TNF-related
apoptosis-inducing ligand (TRAIL) binding to death receptor 4/5, or TNF𝛼 binding to TNFR1
and subsequent recruitment of tumor necrosis factor receptor type 1-associated death domain
(TRADD). Pro-apoptotic (intrinsic and extrinsic pathways) and inflammatory factors such as Fas
L, Fas, P53, BAX, TNF𝛼, and IFN𝛾 protein and mRNA expression are all significantly elevated
following PGF2𝛼 administration (Jonczyk et al., 2019; Kim et al., 2019; Kliem et al., 2009).
However, one research group found no significant difference in TNF𝛼 mRNA expression
throughout the luteal phases and found no difference in TNFR1 expression in the late and
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regressing CL (Sakumoto et al., 2000). The lack of differential expression could, in theory, be
due to a shifting phenotype that prepares a CL for regression by synthesizing and storing
receptors in Golgi-associated vesicles for later exocytosis if no pregnancy is detected, therein
expediting time until the following ovulation. Anti-apoptotic and pro-survival mRNA transcripts
are also significantly elevated, such as TNFR2 and BCL-extra-large (BCL-XL) (Kliem et al.,
2009; Sakumoto et al., 2011). and may be attributed to cellular efforts to stave off cell death, and
(or) an effort to control the pace of cell death to ensure it remains a controlled, localized event.
One group proposes that the external apoptotic pathway is the primary route of apoptosis during
luteal regression (Kliem et al., 2009). Additionally, it has been postulated that luteal regression
causes a localized elevation in reactive oxygen species (ROS) that in turn further propagates
luteal regression by way of increased cell death (namely apoptosis) and reduced steroidogenesis
(Kato et al., 1997). A ROS is a molecule with a free radical-containing oxygen, which when
accumulated in abundance, can cause irreparable damage to genetic material and proteins therein
triggering programmed cell death. In multiple species, including bovine, concentrations of luteal
ascorbate (the primary antioxidant in the CL) plummet following PGF2𝛼 exposure or during
natural luteolysis (Aten et al., 1992; Endo et al., 1993; Petroff et al., 1998; Tsai & Wiltbank,
1998). Interestingly, pre-treatment of a potent ROS scavenger (superoxide dismutase/catalase) in
luteal cell culture following exposure to cytotoxic doses of TNF𝛼 and IFN𝛾 significantly
reduced loss in cell viability, furthering the notion that TNF𝛼 and IFN𝛾 stimulate cell death by
way of ROS production (Petroff et al., 2001).
Evidence that an additional form of programmed cell death, necroptosis, occurs during
luteal regression has begun to emerge (Jonczyk et al., 2019). Necroptosis, like almost all cellular
signaling, is a complex network involving multiple inputs and outputs that depend on external
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stimuli and the internal cellular environment. Necroptotic signaling can be instigated through
multiple plasma membrane receptors, namely toll-like receptors, death receptors, and TNFR1. A
well-established pathway includes the TNFR1, wherein ligation via TNF𝛼 recruits a TNFreceptor-associated death domain (Galluzzi et al., 2017; Linkermann & Green, 2014). Through a
series of ubiquitination and deubiquitinating steps, receptor-interacting protein kinase 1 (RIPK1)
transforms from a pro-survival to a pro-death activated state. A pro-death activated RIPK1, in
combination with inhibited caspase 8 and (or) FLICE inhibitory proteins (FLIP), activates and
associates with receptor-interacting protein kinase 3 (RIPK3) to form the necrosome. The
necrosome will then target and activate mixed lineage kinase domain-like (MLKL) protein,
which instigates an influx of calcium ions, effectively disrupting the osmotic gradient and lysing
the cell (Gong et al., 2017). The rupture of the cell resembles the phenotypic damage of necrosis.
Hojo et al. (2019) demonstrated that TNF𝛼 and IFN𝛾 synergistically increased cell death via
necroptotic signaling in bovine endothelial cells. Since both TNF𝛼 and IFN𝛾 are elevated during
luteal regression, it is plausible that through TNFR1 signaling, necroptosis occurs in bovine
luteal cells.
Progesterone Biosynthesis
Progesterone synthesis in small and large luteal steroidogenic cells beings with the
precursor cholesterol. Steroidogenic cells utilize esterified cholesterol from circulating lowdensity lipoproteins via the low-density lipoprotein receptor or from high-density lipoproteins
via the scavenger receptor B1 as the primary source of cholesterol (Miller & Bose, 2011). Cells
can also isolate cholesterol from lipid bilayers of biological membranes or esterified cholesterol
from lipid droplets (Steck & Lange, 2010). Esterified cholesterol is removed from lipid droplets
via hormone-sensitive lipase and subsequently converted to free cholesterol (Miller & Bose,
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2011). While it remains the least common source, most likely due to the inefficiency, cells can
synthesize cholesterol de novo from acetate in the endoplasmic reticulum (Porter & Herman,
2011; Steck & Lange, 2010).
Progesterone synthesis begins with free, unesterified cholesterol, which is transported
across the mitochondrial membranes. While the detailed mechanisms of transport are unknown,
STAR plays a pivotal role in the mitochondrial transport of cholesterol, which serves as the ratelimiting step in the enzymatic synthesis of progesterone. Additionally, studies have demonstrated
that lipid droplets may be trafficked and doc with the mitochondria to facilitate cholesterol
transport (Miller & Bose, 2011). Within the inner mitochondria membrane, P450scc
enzymatically converts cholesterol to pregnanolone through cleavage of the 6-carbon acyl side
chain of cholesterol (Miller & Bose, 2011). Pregnanolone is then shuttled out into the cytosol by
an unknown mechanism. Within the cytosol or the endoplasmic reticulum, pregnanolone is
converted to progesterone by way of an alkene rearrangement from carbon 5 to carbon 4,
catalyzed by 3𝛽-HSD. A summary of the steroidogenic pathway can be visualized in figure 1.3.
Miller and Bose (2011) and Bishop et al. (2022) provide a more extensive review of proteins and
pathways involved in cholesterol trafficking and progesterone synthesis.
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Figure 1.3
Progesterone Production in Bovine Luteal Steroidogenic Cells

Note. Luteal steroidogenic cells sequester cholesterol esters (Chol ester) from low density
lipoproteins (LDL) and high-density lipoproteins (HDL) circulating in blood, from lipid droplets,
the plasma membrane, or de novo from the endoplasmic reticulum (not shown). Free,
unesterified cholesterol (Chol free) is transported into the mitochondria by steroidogenic acute
regulatory protein (STARD1), where it is converted to pregnenolone (P5) by cholesterol sidechain cleavage enzyme (p450scc). P5 is then converted in the endoplasmic reticulum (or
cytoplasm) to the final product progesterone (P4).
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Influence of Cytokines on Bovine Luteal Cells
Tumor Necrosis Factor Alpha
The term TNF𝛼 was first used and reported in 1975 by Carswell et al. to describe the
molecule responsible for the hemorrhagic necrosis observed in tumors following endotoxin
exposure. While TNF𝛼 was first described as a cytotoxic and pro-inflammatory polypeptide, it
has been well established that the cytokine is pleiotropic depending on abundance, receptor
signaling, and other extracellular immune factors (Aggarwal, 2003). For example, with regards
to differential TNF𝛼 concentrations a low dose (1 ug) of systemically administered TNF𝛼
significantly reduced progesterone output, whereas a high dose (10 ug) increased progesterone
output, though not significantly (Korzekwa et al., 2008). Sources of TNF𝛼 in the bovine CL
include immune cells, large and small luteal cells, and endothelial cells (Sakumoto et al., 2011).
TNF𝛼 is a part of the TNF superfamily, which comprises upwards of 19 ligands and 29 TNFRs
(Aggarwal, 2003). The TNFRs can be further subdivided into two categories: death domainassociated receptors (death receptors) and those without (survival receptors). TNF𝛼 specifically
binds to TNFR1 and TNFR2 (Aggarwal, 2003). TNFR1 receptors have been identified in bovine
luteal endothelial cells and steroidogenic cells, whereas TNFR2 receptor expression is
predominantly associated with endothelial cells and immune cells (Aggarwal, 2003; Hojo et al.,
2010; Kim et al., 2019). While TNFR1 is generally regarded as a death receptor due to the
intracellular FADD binding domain, and TNFR2 as a proliferative survival receptor due to the
TNF receptor-associated factor (TRAF) binding domain, potential crosstalk may occur between
receptors (Faustman & Davis, 2013; Fotin-Mleczek et al., 2002; Yan et al., 2018). Additionally,
the abundant expression of TNFR2 during luteal regression may be indicative of a pro-death
cascade, though could be pro-survival and homeostatic in conjunction with Pate et al.’s (2012)
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previously discussed theory that immune cells aid to reduce luteal cell death during regression
(Pate & Keyes, 2001; Sakumoto et al., 2011).
The TNFR1 signalling cascade commences with the ligation of TNF𝛼 to TNFR1. Upon
receptor activation, TRADD is recruited which can in turn activate multiple different signalling
pathways, depending on additional stimuli (Aggarwal, 2003). Both apoptotic and necroptotic
signaling pathways are potential outcomes of TNFR1 activation, as previously discussed.
Additionally, TNFR1 stimulation can trigger nuclear factor kappa B activation, which is a known
transcription factor for genes of an inflammatory descent (Liu et al., 2017).
The TNFR2 receptor recruits and binds TNF receptor-associated factors (TRAF) and
cellular inhibitors of apoptosis (CIAP), which collectively and predominantly promote cell
survival (Faustman & Davis, 2013). Following exposure to TNF𝛼, middle-cycle luteal cells in
culture increased PGF2𝛼 and PGF1𝛼, but not progesterone output (Benyo & Pate, 1992).
Additionally, TNF𝛼 exposure alone increased the expression of class I MHC molecules.
Exposure to TNF𝛼 for 24 hrs reduced luteal endothelial cell culture viability by 40%, which was
entirely inhibited by a potent antioxidant, glutathione, indicating TNF𝛼 may be increasing
cellular death via ROS production (Pru et al., 2003). Additionally, TNF𝛼 alone reduces the
inhibitor of nuclear factor kappa B, nuclear factor of kappa light polypeptide gene enhancer in Bcells inhibitor alpha, in cultured bovine luteal cells (Suter et al., 2001).
Interferon Gamma
Like TNF𝛼, IFN𝛾 is a pleiotropic cytokine, influencing cellular death and cellular
differentiation. IFN𝛾 was first reported in 1965 by Wheelock as a cytokine released by immune
cells in response to a virus (Wheelock, 1965). IFN𝛾 belongs to the IFN class of cytokines, which
is subdivided into Type 1 or Type 2 IFN. Type 1 IFN, such as IFN alpha, IFN beta, and IFN𝜏 are
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mainly produced in response to viral infections. Type 2 IFN, IFN𝛾 being the sole member, is
produced in response to a pro-inflammatory environment. IFN𝛾 is secreted by an array of
immune cells present in the four luteal stages of the corpus luteum, such as helper T cells,
cytotoxic T cells, B cells, natural killer cells, and monocytes and macrophages. Production and
secretion of IFN𝛾 are regulated by both interleukin 12 and interleukin 18, as reviewed by
Schroder et al. (2004). On the contrary, IFN𝛾 is negatively regulated by interleukin 10 and 4 and
transforming growth factor-beta, and vice versa (Neuvians et al., 2004). The IFN𝛾 receptor
(IFNGR) consists of two ligand-binding domains (IFNGR1) and two signal-transducing regions
(IFNGR2). The IFNGR2 serves as a control point for IFN𝛾 signalling, as the gene expression is
highly regulated (Bach et al., 1997). Activation of the IFNGR initiates a JAK-STAT signalling
cascade resulting in transcriptional regulation of interferon-stimulated genes (Schroder et al.,
2004). Expression of the IFN𝛾 receptor is not well defined in the bovine corpus luteum,
however, exposure of the cytokine to steroidogenic luteal cells, endothelial cells, and immune
cells alters cellular functionality and mRNA expression of IFN𝛾 signalling, indicating a
regulatory role of IFN𝛾 on these cells (Suter et al., 2001). Furthermore, across species,
IFN𝛾increases the activity of cellular immunity through the activation of macrophages, natural
killer cells, and T cells (Schroder et al., 2004). IFN𝛾 has also been shown to independently
increase class II MHC in bovine luteal cells (Fairchild & Pate, 1989). Following prolonged IFN𝛾
exposure (greater than 24 h), cultured bovine luteal cells increase PGF2𝛼 and PGF1𝛼
production, and reduce progesterone synthesis in a PGF2𝛼-independent manner (Fairchild &
Pate, 1991). Despite the influence of IFN𝛾 on prostaglandins and progesterone synthesis, one
group demonstrated that IFN𝛾 on its own marginally reduces the cellular viability of cultured
luteal cells (Pru et al., 2003). However, Hojo et al. (2010) demonstrated that a low dose of IFN𝛾

33
(2.5 nM) reduced cell viability by a near 40%. Moreover, a group exhibited that IFN𝛾 increased
indoleamine 2,3 dioxygenase, which is involved in tryptophan degradation, and potentially
serves as a mechanism by which IFN𝛾stimulates luteal apoptosis (Cannon & Pate, 2006;
Fallarino et al., 2002).
Synergistic Influence of Tumor
Necrosis Factor Alpha and
Interferon Gamma
Both TNF𝛼 and IFN𝛾 independently alter luteal cell functionality. However, a synergistic
effect is observed when cytokine treatments are combined. For example, TNF𝛼 and IFN𝛾
exposure to middle-cycle cultured luteal cells reduced luteal cell viability by 70-80% (Benyo &
Pate, 1992; Hojo et al., 2010). The combination of cytokines also synergistically reduced
cultured luteal endothelial cells (Pru et al., 2003). How the cytokines synergistically increase cell
death is not well known. However, IFN𝛾 increases expression of TNFR1 receptor expression in
bovine luteal endothelial cells, and so it has been hypothesized that IFN𝛾increases the sensitivity
of cells to TNF𝛼 (Hojo et al., 2010). Petroff et al. demonstrated that TNF𝛼 and IFN𝛾-induced
cell death was significantly reduced by pre-treatment with two potent antioxidants, indicating a
role of ROS in the induced cellular death, as previously mentioned (Petroff et al., 2001).
Notably, ascorbate is depleted from cells over time in culture and may leave cells more
susceptible to ROS generation (Musicki et al., 1996). Moreover, apoptosis and necroptosis occur
following TNF𝛼 and IFN𝛾 exposure, as previously discussed (Hojo et al., 2016, 2019).
While TNF𝛼 and IFN𝛾 are certainly cytotoxic to middle-phase bovine luteal cells, how
the cytotoxicity changes over the course of the luteal phases (early, middle, and late) has not yet
been explored. In consideration of the differential expression of TNFR1 through the luteal
phases, as previously discussed, we postulate that mixed luteal cells from the early, middle, and
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late luteal stages will undergo differential losses in cell viability following exposure to low doses
of TNF𝛼 and IFN𝛾. Specifically, late and regressed luteal phases will have a higher percentage
loss in viability when compared to cells isolated during the early and middle luteal phases.
Omega-3 Fatty Acids in Reproductive Biology
Lipids are defined as a class of organic compounds that are soluble in organic solvents,
which are essential in the diet. The feed industry uses crude fat as an estimate of lipid content in
a feedstuff. Crude fat is a mixture of lipids in a sample that has been extracted using the Soxhlet
method. This mixture contains fatty acids, mono- di- and triglycerides, steroids, and fat-soluble
vitamins.
Cows bred in negative energy balance or poor body condition have decreased pregnancy
rates. A cow ration contains approximately 2 to 3% crude fat and fats are often supplemented in
the diet to improve energy balance and body condition. However, there are conflicting reports in
the literature regarding fat supplementation and impacts on reproduction, some showing
improved rates of pregnancy, while others show no change (Funston, 2004; Hess et al., 2008).
The class of fat incorporated into the diet may differentially support reproductive performance.
Lipids or fats can be further defined as simple, compound or lipid derived. Simple lipids
include long-chain fatty acids (saturated, unsaturated, polyunsaturated), triglycerides and waxes.
Long-chain fatty acids are named by number of atoms carbon in the acyl chain, number of C=C
bonds and the position of these bonds in the acyl chain. There are two systems used in the
naming of long-chain fatty acids that have C=C bonds – omega and delta numbering system. The
delta nomenclature has been adopted by biochemists and number the carbon atoms starting from
the carboxy terminal, while the omega nomenclature has been adopted by nutritionists and
number the carbon atoms starting from the methyl end. Omega-3 fatty acids are long-chain fatty
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polyunsaturated acids with the first C=C bond between the third and fourth carbon atom. There
are three common omega-3 fatty acids found within animal and plant cells. The first of the three,
alpha-linoleic acid (ALA; shorthand C18:3n-3) is an essential fatty acid required in the diet as
mammals lack enzymes required for de novo synthesis. However, mammals do express
desaturase and elongase enzymes that allow for the synthesis of two other common omega-3
fatty acids—eicosapentaenoic acid (EPA; shorthand C20:5n-3) and docosahexaenoic acid (DHA;
shorthand C22:6n-3)—from ALA. However, the conversion efficiency of ALA to the longer
chain omega-3 fatty acids EPA and DHA is low in cattle, and thus dietary supplementation of
EPA and DHA has been recommended (Kairenius et al., 2015). Omega-3 fatty acids from fish
meal supplementation significantly surpasses de novo blood plasma concentrations (Petit et al.,
2002; Plewes et al., 2018).
Fish products are a rich source of EPA and DHA and have been selectively utilized in
both the beef and dairy industry for over a century to optimize meat and dairy production
(Avramis et al., 2003; Bimbo & Crowther, 1992; Wistuba et al., 2006). In addition to improved
meat and milk production, dietary supplementation with fish meal or oil has shown potential for
improving reproductive biology functions and pregnancy in cattle. In dairy cows,
supplementation has shown to reduce PGF2𝛼 release from the endometrium (Coelho et al., 1997;
Mattos et al., 2004). However, additional groups found no reduction in PGF2𝛼 metabolite (one
group found increased output) nor found any difference in follicular activity or progesterone
output in cattle supplemented with fish meal (Childs et al., 2008; Moussavi et al., 2007). Burke
et al. (1997) demonstrated that fish meal supplementation increased pregnancy rates by 29.5%
(9.4% difference), increased luteal progesterone, and altered CL responsiveness to PGF2𝛼 in
dairy cattle. Furthermore, a combination of omega-6 fatty acids, followed by omega-3 fatty acids
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on day 40 of gestation increased pregnancy rates in dairy cows (Dirandeh et al., 2013). A study
by Burns et al. (2002) furthered the notion that fish meal supplementation increased pregnancy
rates by 22.6 % (14% difference), specifically in primiparous lactating beef cows.
Fish meal supplementation has also been demonstrated to reduce rates of luteal regression
following physiological intra-uterine infusions of PGF2𝛼 (Plewes et al., 2018). While the
mechanisms involved are not well elucidated, it is evident that the omega-3 fatty acids derived
from fish meal or oil are altering reproductive function in cattle (Gulliver et al., 2012).
Generally, mechanisms explored regarding omega-3 fatty acids and their role in overall health
optimization pertain to the anti-inflammatory qualities of the lipids and subsequent metabolites
(Serhan et al., 2008). This idea is paralleled in studies where the production of the proinflammatory lipid, PGF2𝛼, is underproduced and secreted in the bovine endometrium (as
previously mentioned). Additionally, the observed reduction in luteal regression and increased
output in progesterone following fish meal or oil supplementation may be in part due to a
repressed intra-luteal inflammatory response, though requires further exploration. As discussed
in previous chapters, the event of luteal regression is a localized pro-inflammatory event,
wherein up-regulation of pro-inflammatory cytokines and cell phenotypes are expressed and
contribute to the demise of the gland. We postulate that the luteoprotective effect of omega-3
fatty acid supplementation is in part due to a reduction in cytokine-induced cellular cytotoxicity
on bovine luteal cells (figure 1.4). As previously mentioned, cytokines TNF𝛼 and IFN𝛾 may
reduce cellular viability by way of increased generation of ROS (Petroff et al., 2001; Pru et al.,
2003). Although the role of omega-3 fatty acids, specifically EPA and DHA, in ROS
management is heavily debated and often dependent on cell type, dosage, and cellular
environmental conditions (Al-Gubory, 2012; Giordano & Visioli, 2014; Hsu et al., 2014; Jones
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et al., 2013; Lee et al., 2015; Oono et al., 2020; Sakai et al., 2017; Wu et al., 2009). We propose
that if EPA and DHA do indeed maintain luteal cell viability, that it is by way of ROS
repression. An additional proposed mechanism by which fish meal supplementation maintains
luteal functionality includes the preservation of luteal blood flow following low-dose intrauterine PGF2𝛼 exposure. Omega-3 fatty acids have been shown across systems and models to
maintain and influence blood flow, indicating an influential role of these lipids in tissue
vascularization (Howe et al., 2018; Lescano de Souza Junior et al., 2017; Morgan et al., 2006;
Schwarz et al., 2018; Sinn & Howe, 2008; Walser et al., 2006). Prolonging CL blood flow could,
in theory, maintain subsequent cholesterol delivery and nutrient and gas exchange to the gland,
therein prolonging luteal functionality.

38
Figure 1.4
Hypothesized Inhibitory Effects of Eicosapentaenoic Acid (EPA) and Docosahexaenoic Acid
(DHA) on the Cytotoxicity of Tumor Necrosis Factor Alpha (TNFα) and Interferon Gamma
(IFNγ)

Note. During luteal regression, luteal steroidogenic cells, endothelial cells, and immune cells
produce the cytokines TNFα and IFNγ, both of which propagate luteal regression and are
cytotoxic to bovine luteal cells. Here, we hypothesized that both EPA and DHA reduce the
cytotoxic effects of both cytokines (yellow triangle with question mark), and if so, could allude
to a potential mechanism by which fish meal supplementation is luteal protective. If EPA and
DHA do reduce cytotoxicity, we hypothesize it is through reduction of reactive oxygen species
(ROS) production.
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Specific Aims, Research Questions and Hypotheses

A1

Examine differences in cytokine sensitivity of mixed bovine luteal cells
isolated from the early (day 1-4), middle (day 5-12), and late (day 13
17) luteal phases of the estrous cycle.

Q1

Is the degree of TNF𝛼 and IFN𝛾-induced cytotoxicity dependent on the
luteal stage from which mixed bovine luteal are isolated?

H

Mixed bovine luteal cells isolated from the late luteal phase will die more
(higher percent loss in cellular viability) when compared to cells isolated
during the early and middle luteal phase following TNF𝛼 and IFN𝛾
exposure.

Q2

Are biomarkers of apoptotic (BAX, CASP3, BCL2) and (or) necroptotic
(RIPK1, RIPK3, MLKL) signaling pathways both elevated following
TNF𝛼 and IFN𝛾 exposure across all luteal stages?

H2

The abundance of steady state mRNA for necroptotic signaling (RIPK1,
RIPK3, MLKL) will be more abundant in the late luteal phase, and
apoptotic gene expression (BAX, CASP3, BCL2) will not differ throughout
stages.

Q3

How does TNF𝛼 and IFN𝛾 exposure influence pro-inflammatory
(programmed cell death related) gene expression (TNFR1, TNF𝛼, and
NF𝜅B) in bovine luteal cells, and does it vary across luteal stages?

H3

Bovine luteal cells exposed to TNF𝛼 and IFN𝛾 will undergo increased
expression of TNFR1, TNFa and NF𝜅B, though will be
disproportionately elevated in cells isolated from the late luteal phase
compared to those of early and middle stage CL.

Q4

What is the influence of TNF𝛼 and IFN𝛾 exposure on steroidogenic gene
expression (STARD1 and CYP11A1) in bovine luteal cells?

H4

Bovine luteal cells exposed to TNF𝛼 and IFN𝛾 will undergo a reduction in
STARD1 and CYP11A1 steady state mRNA expression.

A2

Explore the influence of EPA and DHA pre-treatment on the TNF𝛼 and
IFN𝛾 induced cytotoxicity in mixed bovine luteal cells.

Q1

Does pre-treatment of bovine luteal cells with EPA and DHA influence
the cytotoxicity of TNF𝛼 and IFN𝛾 exposure?
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H1

Pre-treatment of mixed bovine luteal cells with EPA and DHA will
reduced the cytotoxic effects of TNF𝛼 and IFN𝛾 exposure.

Q2

Independent of changes in cellular viability, does pre-treatment of bovine
luteal cells with EPA and DHA differentially alter gene expression for
apoptotic (BAX, CASP3, BCL2) or necroptotic (RIPK1, RIPK3, MLKL)
signaling following exposure to TNF𝛼 and IFN𝛾?

H2

EPA and DHA pre-treatment will not differentially influence gene
expression for apoptotic or necroptotic gene expression following
exposure to TNF𝛼 and IFN𝛾

Q3

Does pre-treatment of bovine luteal cells with EPA and DHA influence
expression of steroidogenic genes (STARD1 and CYP11A1) following
TNF𝛼 and IFN𝛾 exposure?

H3

Bovine luteal cells pre-treated with EPA and DHA will undergo a smaller
reduction in steroidogenic gene expression following TNF𝛼 and IFN𝛾
exposure.

A3

Generate preliminary data on the effects of fish meal supplementation on
luteal blood flow following PGF2α induced luteolysis.

Q1

Does luteal blood flow differ in fish meal supplemented cows that
maintained a functional CL 48 hrs following two low dose intra-uterine
infusions of PGF2α?

H1

Cows that were supplemented with fish meal, and that retained a function
CL, will have elevated and prolonged luteal blood flow following two
low doses intra-uterine infusions of PGF2𝛼.
Conclusion

For decades, the loss of pregnancy in cattle has plagued the beef and dairy industry. An
avenue of popular scientific exploration, in pursuit of a solution, includes alterations in dietary
intake. Dietary supplementation with fish meal, a rich source of the omega-3 fatty acids EPA and
DHA, has shown promise across multiple studies to positively influence pregnancy rates.
However, much is to be gleaned as to how fish meal is a reproductively enhancing supplement
and how it alters the physiology of reproductive structures. Past studies from our lab demonstrate
that fish meal supplementation reduces the rate of luteal regression following low dose infusions
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of PGF2𝛼. Despite some insight as to how fish meal supplementation influences CL-PGF2𝛼
sensitivity, such as increased PGF2𝛼 receptor mobility and subsequent reduction in downstream
signaling, the presumed vastness of the physiological changes has yet to be delineated. Also,
exploring and outlining the mechanisms at play will further our understanding of luteal
regression, which is imperative for further development of pregnancy rate- augmenting
interventions.
During luteal regression, the pro-inflammatory cytokines TNF𝛼 and IFN𝛾 appear to
contribute to the functional and structural demise of the gland, and as such are particularly
cytotoxic to bovine luteal cells. The cytokines may be inducing cellular death by elevating
production of ROS, and both EPA and DHA have demonstrated a capacity to reduce damage
associated with, and production of, ROS in cells and tissue. Furthermore, changes in luteal blood
flow, specifically the decline following PGF2𝛼 exposure, are postulated to play a significant role
in the cessation of luteal function. Omega-3 fatty acids have demonstrated a capacity to maintain
tissue blood flow, despite damage or restriction to said tissue. Taken together, we hypothesized
two potential mechanisms by which fish meal supplementation alters rates of luteal regression:
1) omega-3 fatty acids reduce the cytotoxic effects of TNF𝛼 and IFN𝛾 and 2) fish meal
supplementation maintains luteal blood flow following exposure to PGF2𝛼.
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CHAPTER II
METHODOLOGY
The Influence of Eicosapentaenoic Acid and Docosahexaenoic Acid
on Tumor Necrosis Factor-Alpha and Interferon GammaInduced Cytotoxicity on Mixed Bovine Luteal Cells
Bovine Corpus Luteum Enzymatic
Digest and Cellular Preparation
Bovine Holstein and Angus ovaries were retrieved from Double J Meatpacking Inc in
Pierce, Colorado. Reproductive tracts were palpated for absence of an embryo/fetus and both
ovaries were assessed for the presence and size of follicles for later staging of the corpus luteum.
Ovaries were transported to the University of Northern Colorado laboratory on ice in 1×
Dulbecco’s phosphate-buffered saline (dPBS) within 1-hr following slaughter. Ovaries were
briefly sterilized in 70% ethanol and subsequently rinsed in ice-cold calcium, magnesium, and
phenol red-free Hanks' Balanced Salt Solution (HBSS; pH 7.34; ThermoFisher 14175095). To
determine the stage of the CL, gross anatomical structures on the ovary were used as identifiers,
as previously defined by Ireland et al. (1980). The CL was then dissected from the ovary, along
with the removal of external connective tissue, and measurements of glandular diameter and
coloration were recorded for use in luteal staging. The corpus luteum was further dissected into
500 µm thick slices, using a handheld microtome. Throughout the dissection process, tissue
slices were placed on ice in a petri dish containing Ham’s F-12 Nutrient Mix (pH 7.34;
ThermoFisher 11765062) supplemented with 1× Antibiotic-Antimycotic (ThermoFisher
15240062). Tissue slices were then transferred to a sterile glass Pyrex bottle containing 20 mL of
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Ham’s F-12 Nutrient Mix and 1× Antibiotic-Antimycotic, and a magnetic stir rod, as described
by Pate and Condon (1982). Pyrex bottles and contents were placed in a 35oC water bath and left
to gently mix for 10 mins. The culture medium was then decanted from the tissue, and 20-30 mL
of fresh media containing type 1 collagenase (2000 U/g tissue; Worthington LS004197) was
added. The tissue-collagenase mixture was placed back into the 35oC water bath and left to stir
for 45 mins. Every 15 mins the tissue was slowly passed through with a plastic 25 mL
serological pipette 15 – 20 times to facilitate tissue disruption. The supernatant was then
decanted from the residual tissue chunks and filtered with a 100 µm cell strainer into a 50 mL
conical on ice for later processing. The residual tissue chunks were resuspended in another 20
mL of collagenase-containing medium for further digestion. Once all tissue was fully digested
and filtered, cells were centrifuged at 300 × g for 7 mins at 4OC. Cells were then resuspended
and rinsed in 1× dPBS, followed by subsequent centrifugation for 3 rounds, or until the
supernatant was clear of debris. Cells were then filtered a final time using a 100 µm cell strainer,
resuspended in Ham’s F-12 Nutrient Mix supplemented with 1× antibiotic-antimycotic, 1×
Insulin-Transferrin-Selenium (ITS-G; ThermoFisher 41400045) and 10% fetal bovine essence
(FBE; VWR 3100-500GH); complete culture medium. Cell concentration and viability was
determined using a hemacytometer and trypan blue exclusion. Cells were either plated
immediately for select assays or were plated in T-225 flasks (2 × 107 cells/ flask) for future
experiments and incubated at 37 °C in 5% CO2 and 95% humidified air. The incubation
parameters were consistent across all in vitro experiments.

44
Estimation of Steroidogenic Cell
Population in Bovine Luteal
Cell Culture
A nitro tetrazolium blue chloride assay was performed as per Hryciuk et al. (2019) to
estimate the percentage of cells containing 3β-HSD (steroidogenic cells) in culture at 1, 7, and 11
days following the CL enzymatic digestion. Cells were first removed from respective flasks and
1x106 cells were used in each assay. Cells were rinsed three times (300 x g for 5 mins) in 1×
dPBS, and subsequently fixed in 1% paraformaldehyde for 15 mins at 37oC. Cells were rinsed
three more times in 1× dPBS and incubated for 24 hrs at 37oC in 200 µL of dPBS containing
0.25 mM nitro tetrazolium blue chloride (Sigma-Aldrich N6876), 1.5 mM β-nicotinamide
adenine dinucleotide hydrate (NAD+; Sigma-Aldrich N1636), 0.2 mM 5-pregnen-3B-ol-20-one
(Sigma-Aldrich P9129), 0.2 mM ethylenediaminetetraacetic acid disodium salt (EDTA; SigmaAldrich E7889) and 0.1% BSA. Pregnenolone was withheld from negative staining controls.
Data Analysis
The percentage of steroidogenic cells (purple cells) was quantified using a
hemocytometer (

# 𝑝𝑢𝑟𝑝𝑙𝑒 𝑐𝑒𝑙𝑙𝑠
# total cells

) after 24 hrs of incubation.

Statistical Analysis
All data were first assessed for normality using the Shapiro-Wilk test (p>0.05= normal
distribution) with Python (version 3.10.6) prior to statistical analysis. A PROC MIXED model
was used to determine statistical differences between variables using the Statistical Analysis
Software (SAS). Variables included in the model were stage of CL and day of culture postenzymatic digestion, with the CL number as a random variable.
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Omega-3 Fatty Acid
Pre-Treatment
Cells that were pre-treated with omega-3 fatty acids prior to cytokine exposure were first
trypsinized with 0.5% Trypsin-EDTA (ThermoFisher 15400054) from T-225 flasks one day
following CL enzymatic digest. Cells were pre-treated with 10 µM eicosapentaenoic acid (EPA;
Sigma-Aldrich 73167-03-0) and 10 µM docosahexaenoic acid (DHA; Sigma-Aldrich D8768) in
complete medium. The concentration of EPA and DHA (𝜔-3) were previously established by
Plewes et al. (2017) in a dose-response experiment on bovine luteal cell cultures. To ensure the
complete solubilization of the 𝜔-3, fatty acids were pre-bound to 33 mg/mL bovine serum
albumin (BSA; Sigma-Aldrich 7030) in complete medium prior to exposure to cells, as
previously described by Mattos et al. (2003). Cells were then left to incubate for 72 hrs in the ω3-integrated culture medium.
Cytokine Exposure to Mixed
Bovine Luteal Cells
When investigating the influence of ω-3 or luteal stage on the cytotoxicity of tumor
necrosis factor alpha (TNFα) and interferon gamma (IFNγ), all cytokine concentrations and
plating numbers were the same.
Cells were first plated in triplicate in a 96-well plate (3000 cells/well) in complete
medium. Cells were serum starved with serum-starve culture media (complete culture medium
with only 1% FBE) for 12 hrs to force all cells into the G0 phase of the cell cycle. Next, cells
were exposed to 2.5 nM bovine recombinant TNFα (R&D Systems 210-TA-100) and 2.3 nM
bovine recombinant IFNγ (R&D Systems 2300-BG-025) in serum-starve culture media and
cultured for 0, 12, 24, 36, or 48 hrs. Concentrations of TNFα and IFNγ were previously
established by Hojo et al. (2010). Depending on the relevant experiment, treatment groups
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included BSA control (BSA), TNFα & IFNγ treated (BSA TI), EPA & DHA pre-treated control
(ω-3), and ω-3 pre-treated and TNFα & IFNγ treated (ω-3 TI).
Adenosine 5-Triphosphate
Luminescence Cell
Viability Assay
Following exposure to TNFα and IFNγ, cellular viability was assessed using the
luminescent CellTiter-GloR 2.0 Cell Viability Assay (Promega G9241), which quantifies ATP
levels. The protocol provided by Promega (TM403; Revised 10/18) was followed. Briefly,
before the addition of the CellTiter-GloR reagent (100 uL) to the 96 wells, 100 uL of the culture
media was removed and discarded to ensure the final volume was compatible with the 96 well
format. Following the addition of CellTiter-GloR reagent and complete cellular lysis, the contents
of each well were transferred to identical wells in a white opaque-walled 96-well plate to reduce
luminescent cross talk. Before the final analysis, any bubbles were removed using a propane
torch briefly held over the top of the 96-well plate. Luminescence was assessed using the Perkin
Elmer Victor X5.
Data Analysis
An average value per treatment (BSA Cont, BSA TI, ω-3 Cont, ω-3 TI), per CL was
normalized to the respective non-cytokine treated BSA controls
treatment average luminescence value

(BSA control average luminescence value), providing relative viability.
Statistical Analysis
All data were assessed for normality using the Shapiro-Wilk test, as previously outlined.
If data were normally distributed following transformation, a PROC MIXED model was used to
determine statistical differences between variables with SAS. When analyzing the influence of
luteal stage on the cytotoxicity of TNFα and IFNγ, variables included in the model were isolated
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CL, stage of CL, time of cytokine exposure, and all possible interactions. If main effects or
interactions were significant (p<0.05), a preplanned pairwise t-test comparisons analysis was
used with the PDIFF function to determine statistical differences between groups. When
assessing the influence of EPA & DHA pre-treatment on the cytotoxicity of TNFα and IFNγ,
variables included stage of CL, time of cytokine exposure, treatment group, and all possible
interactions. The number of isolated CL was set as a random variable. If main effects of
interactions were significant (p<0.05), a preplanned pairwise t-test comparisons analysis was
used with the PDIFF function to determine statistical differences between groups.
Ribonucleic Acid Extraction and Complementary
Deoxyribonucleic Acid Synthesis
Total RNA was isolated to investigate the influence of ω-3 fatty acid treatment and luteal
stage on apoptotic, necroptotic, programmed cell death associated, and steroidogenic genes.
Cells were first plated in duplicate in a 12 well dish (1 x 105 cells/well). All EPA & DHA and
TNFα & IFNγ pre-treatment methodology and concentrations were as previously mentioned.
Cells were exposed to cytokines for 24 h, prior to RNA isolation.
RNA was isolated from cell culture experiments using the Direct-zol™ RNA Kit
(Zymogen) protocol supplied by the manufacturer. Of note, following the addition of TRIzol to
cells, samples were stored at -80oC until further processing. Following isolation, RNA
concentrations were quantified using a Thermo Scientific NanoDrop 2000C Spectrophotometer.
The integrity of the RNA was assessed using a 1% agarose gel electrophoresis.
For the subsequent synthesis of cDNA, the QuantiTect Rev. Transcription Kit (Qiagen
205313) was utilized per the protocol supplied by the manufacturer. Briefly, 1 µg of RNA was
utilized in the genomic DNA wipeout reaction, which was then utilized for cDNA synthesis,
described by Plewes et al. in detail (2018). In brief, the genomic wipeout consisted of a 2-minute
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incubation period at 42oC, following which tubes were directly transported back on ice.
Reactions for cDNA synthesis were incubated at 42oC for 30 mins, followed by a 95oC
incubation for 3 mins. Both the genomic wipeout and cDNA synthesis reactions were performed
using a Bio-Rad T100 PCR Thermal Cycler. cDNA samples were stored at -20oC until time of
qPCR.
Quantitative Polymerase Chain
Reaction and Analysis of
Steady State Messenger
Ribonucleic Acid
All primers used for qPCR (table 1) were first validated (in duplicate) for binding
efficiency using a 10-fold dilution of cDNA commencing with 5 ng, 300 nM of forward and
reverse primers, and 1X QuantiTect SYBR Green PCR Kit (Qiagen 204145) in a 10 uL total
reaction. Thereafter, qPCR reactions (run in duplicate) were run with 5 ng of cDNA, 300 nM of
forward and reverse primers, and 1X QuantiTect SYBR Green PCR Kit in a 10 uL total reaction.
All binding efficiency and qPCR reactions were run for a total of 40 cycles: denaturing at 94oC
for 15 s, annealing at 60oC for 30 s, and amplification at 72oC for 30 s. Analysis of melt curves
following each experiment were performed to ensure single product amplification. All qPCR
reactions were run on a Bio-Rad CFX384 real-time PCR Thermal Cycler. All qPCR experiments
contained a negative template control per gene analyzed.
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Table 1
List of Primer Sequences, Subsequent Product Length (BP) and Sources of Retrieval

Gene

gene name

Forward sequence

Reverse sequence

BP

Source

ACTB

Beta-actin

TTCCAGCAGATGTGGATCAG

AGCCATGCCAATCTCATCTC

154

Plewes et al. (2018)

CASP3

caspase 3

TCAGTCAGTTGGGCACTCTG

CACACCCGTAGCTGTGAAGA

144

Cedillo (2019)

BCL2

B-cell lymphoma 2

TTTGCTTCAGGGTTTCATCC

ATCCTCTGCAGCTCCATGTT

147

Cedillo (2019)

BAX

Bcl-2 Associated X

TCTGACGGCAACTTCAACTG

TCGAAGGAAGTCCAATGTCC

135

Cedillo (2019)

STARD1

Steroidogenic acute regulatory protein

CAGCAGAAGGGTGTCATCAGA

GAGAGGACCTGGTTGATGATG

152

Plewes et al. (2018)

CYP11A1

Cholesterol sidechain cleavage

AGGCAGAGGGAGACATAAGCA

GTGTCTTGGCAGGAATCAGGT

156

Plewes et al. (2018)

RIPK1

Receptor interacting protein kinase 1

GCAATAGCTCCAAGCAGGTC

TGTGCAGCAGGAAGTCATTC

148

Hojo et al. (2019)

RIPK3

Receptor interacting protein kinase 3

CCAGAGAGAGCAGGTTCCAC

AATCAGGCGGTTGTTGTTTC

219

Hojo et al. (2019)

MLKL

Mixed lineage kinase domain-like protein

ACTTCCATCAGCCGACAAAC

CTCCCAGAGGACAATTCCAA

144

Hojo et al. (2019)

NFKB2

Nuclear factor kappa B subunit 2

CCTGCTGAATGCTCTGTCTG

TCCTCCTTCACCTCTGTGCT

102

Talukder et al. (2017)

TNFα

Tumor necrosis factor alpha

CAAAAGCATGATCCGGGATG

TTCTCGGAGAGCACCTCCTC

51

Talukder et al. (2017)

TNFR1

Tumor necrosis factor alpha receptor 1

CACCACCACCATCTGCTT

TCTGAACTGGGGTGCAGA

257

Sakumoto et al. (2000)
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Data Analysis
When analyzing quantity of steady state mRNA for target genes, beta-actin (ACTB) was
used as a reference gene. The fold change of gene expression was quantified using the delta delta
Ct (2-∆∆Ct) method.
Statistical Analysis
All data were assessed for normality in the same manner previously mentioned. If raw
data did not show normal distribution, data were transformed and reassessed. Optimal
transformation exponents were determined using the Box-Cox Normality Plot using Python.
If data were normally distributed, a PROC MIXED statistical model was used to determine
statistical differences between variables, as previously outlined. When comparing gene
expression across treatments (BSA, BSA TI, ω-3, ω-3 TI), the tested variables included stage of
CL and treatment, with the number of CL used set as a random variable. If data were not
normally distributed, a Kruskal-Wallis one-way analysis of variance was run on SAS to
determine overall effects. If effects were significant (p<0.05), a post hoc Conover-Iman Test was
utilized to determine differences of gene expression across treatments. Values were reported as
significant if p<0.05.
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The Effects Fish Meal Supplementation on Luteal Function, Serum
Progesterone, Luteal Blood Flow, and Luteal Mass Following Two
Low Dose Intra-Uterine Infusions of Prostaglandin F2 Alpha
Animal Husbandry
Mixed breed beef cows were purchased from the Centennial Livestock Auction house in
Larimer County, CO. Cattle were transported to, and subsequently maintained for the extent of
the study at the Animal Reproduction Biotechnology Laboratory at Colorado State University in
Fort Collins, CO. All animal care and experimental protocols were pre-approved by the Colorado
State University Institutional Animal Care and Use Committee (Approval #1366). Inclusion
criteria for cows admitted to the study included lack of gross reproductive abnormalities, lack of
reproductive adhesions, lack of cystic follicles, non-pregnant, ovaries present, and normal
ovarian cyclicity. All examinations were performed per rectum palpation and with trans-rectal
ultrasonography in B-mode using a linear rectal probe and ExaPad Mini (IMV Imaging).
Supplementation and
Synchronization
Period
Upon admittance to the study, cows were fed a diet of 95% mixed hay and 5%
supplement (table 2). Dry matter intake was at 2.0% total body weight, which averaged 13.6 kg
mixed hay and 0.68 kg supplement per cow. Cows were matched by body weight and randomly
assigned to a fish meal supplementation group or a corn gluten meal supplementation group (5%
total diet)—both of which were isocalorically and isonitrogenously matched by addition of 25
mL of vegetable oil to corn gluten meal groups (table 3). All nutritional parameters met or
exceeded guidelines set by the National Research Council for non-lactating beef cows. Cows
were individually penned twice daily from 06:00-09:00 and 18:00-21:00 (or until complete
dietary consumption) and received respective hay and supplement. When animals were not
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feeding, water and shelter were accessed ad libitum. Animal body weights were assessed every
three weeks, and respective dry matter intake masses were altered accordingly. The total
supplementation period consisted of approximately 63 days (Figure 2.1).
Cows’ estrous cycles were synchronized with 25 mg Dinoprost (a prostaglandin F2 alpha
synthetic analogue; Zoetis 708-901) on day 35 and 49 of the approximately 63-day
supplementation and synchronization period in preparation for the experimental period. Cows
were observed for signs of estrus behaviors 30 mins prior to and following morning and evening
feedings. Estrus detector patches (Estrotect) were also applied to the tail-head region of the cow
to aid in detection of estrus (figure 2.1).

Table 2
Mixed Hay Nutrient Dry Matter Basis
Nurtient
Crude protein
Fat
Acid detergent fiber
Neutral detergent fiber
Starch
Water soluble carbohydrates with fructans—starch
Ethanol soluble carbohydrates—startch

Dry Matter Basis
18.1 %
2.81 %
30.2 %
49.0 %
1.1 %
9.4 %
7.0 %

Table 3
Percent of Crude Fat and Protein in Corn Gluten Meal (CM) and Fish Meal (FM)
Supplementations
Nutrient
Crude fat
Crude protein

CM Supplement
3.0 %
60.0 %

FM Supplement
9.0 %
60.0 %

53
Figure 2.1
Schematic Diagram of the Supplementation & Synchronization Period and the Experimental
Period

Note. During the supplementation and syncornization period, cows were supplemeneted with fish
meal (FM) or corn gluten meal (CM) for 63 days, in conjunction with mixed hay. On days 35
and 49 of the supplementation and syncronization period, estrous cycles were syncronized with
25 mg intramuscular (IM) injections of a prostaglandin F2 alpha (PGF2α) synthetic analouge,
Dinoprost. At the start of the experimental period (day 63, 0 h), cows’ were of day 10-12 post
estrus, bearing a middle cycle corpus luteum. At 0 h and 12 h of the experimental period, cows
were infused in the uterine horn ipsolateral to the corpus luteum-bearing ovary with low dose
infusions of either Dinaprost (0.5 mg in 0.25 mL saline) or saline (0.25 mL). Following each
infusion, luteal blood flow was analyzed with power Doppler ultrasongraphy (frequency 6 MHz,
PFR 2000 Hz, wall filter 2, gain 18, and depth 60 mm) every 15 mins for the first hour, and
every 60 mins for the following 6 h. Following each infusion, jugular blood was drawn for future
analysis of serum progesterone concentrations. Ovariectomies were performed 30 or 48h
following the first infusion.
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Plasma Fatty Acid Composition
and Abundance
Previous studies have demonstrated that fish meal supplementation at an identical dry
matter intake rate is sufficient for fatty acid incorporation into the blood (Plewes et al., 2018). To
ensure cows from the study were undergoing the same rate of incorporation, weekly plasma
samples were acquired for future analysis with liquid gas chromatography (GC). All blood
samples were collected from the jugular vein of cows and inverted in BD vacutainer EDTA
blood collection tubes to prevent clotting. Samples were transported back to the laboratory at the
University of Northern Colorado, wherein samples were spun down at 1500 x g for 15 mins at
4oC. The plasma was then isolated and stored at -20oC until further analysis.
Gas Liquid Chromatography
Prior to analysis of plasma fatty acid composition and abundance, samples first
underwent saponification and methylation reactions, as described by O’Fallon et al. (2007).
Concisely, following a room temperature thaw, 1 mL of plasma sample was subsequently
transferred to a 13 X 100 mm Borosilicate glass tubes (VWR 47729-572). Samples were then
dried with a freeze drier overnight. Thereafter, 5.3 mL of methanol and 0.7mL of 10 M
potassium hydroxide were added to samples. Teflon tape was used on the glass tube and cap
threads to ensure formation of a complete seal. Samples were then incubated at 55oC for 1.5 h,
thereby allowing for optimal saponification conditions. Samples were vortexed every 20 mins for
5 s to dissolve, hydrolyze, and permeate the sample. Next, samples were placed in a cold-water
bath and left to cool until room temperature. Then, 0.58 mL of 12.5 M sulfuric acid was added to
each sample and tubes were subsequently inverted until formation of white potassium sulfate
precipitate. Tubes and contents were then incubated at 55oC for 1.5 hrs, effectively methylating
all samples. Throughout the incubation period, tubes were vortexed every 20 mins for 5 s. Tubes
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were once again placed in a cold-water bath and left to cool until room temperature. Once
cooled, 3 mL of hexane was added to each tube. Tubes were then vortexed for 5 mins. Samples
were centrifuged for 5 mins at 450 x g The hexane layer was then removed from the glass tubes
and placed into 15x 28 mm glass GC vials (Kimble 60810 1528). Samples were either dried
down with nitrogen gas for immediate analysis on the Agilent 7890A Series GLC with
spectrometry detector or stored at -20oC for later analysis.
Data Analysis. GLC analysis was performed as previously described by Plewes et al.
(2017).
Statistical Analysis. Prior to statistical analysis of data, normality was assessed using
methods previously mentioned. A PROC MIXED with repeated measures was used as
previously outline. An autoregressive covariance structure (type=AR (1)) was used in the
repeated measures model. Variables included in the model were cow, day, supplementation, and
supplementation x day. If main effects of interactions were significant (p<0.05), a preplanned
pairwise t-test comparisons analysis was used with the PDIFF function to determine statistical
differences between groups.
Experimental Period
Baseline Luteal Blood Flow and
Serum Blood Draws
Cows in the experimental period were all of day 10-12 post estrus, therefore all CL were
of the middle luteal stage. Prior to commencement of the experimental period, all cows’ ovaries
were scanned to ensure singular ovulation (polyovulation would exclude cows from the study)
and presence of a CL. A baseline ultrasound scan (-15 mins) of the luteal blood flow was taken
trans-rectally in power mode. All ultrasound videos performed during the experimental period

56
were as follows; frequency 6 MHz, PFR 2000 Hz, wall filter 2, gain 18, and depth 60 mm. Data
from vessels with a flow range of 0-0.3 cm/s were captured.
A baseline jugular vein blood draw (-15 mins), for future serum progesterone analysis,
was also performed. All blood samples for the experimental period were collected using glass
vacutainer blood collection tubes with no additives. Samples were left to clot at 4oC for 2 hrs.
Thereafter, using wooden applicators, platelets from blood samples were shear activated against
the wall of the blood tubes. Samples were then centrifuged at 1500 X g for 15 mins at 4oC. The
serum fraction was isolated and stored at -80oC for future serum progesterone analysis.
Intrauterine Infusions
Following baseline assessments, cows were infused with an artificial insemination stylet
preloaded with either 0.25 mL saline or 0.5 mg Dinoprost (prostaglandin F2 alpha analogue) in
0.25 mL saline. All artificial insemination straws (0.25 cc polyvinyl AI straws) were directly preloaded before infusions. Infusions were given in the uterine horn ipsilateral to the CL-bearing
ovary at 0 hrs and 12 hrs of the experimental period. Cows were randomly assigned to an
infusion group prior to the commencement of the experimental period.
Luteal Blood Flow and Serum
Progesterone
Following infusions, luteal blood flow was analyzed using transrectal ultrasonography in
power mode with the same parameters as previously listed in the baseline assessment. Luteal
ultrasound scans occurred every 15 mins for the first hour, and every 60 mins thereafter for a
total of 6 hrs—12 hrs total when considering both infusions. A final ultrasound scan was taken
immediately prior to ovariectomies (30 hrs or 48 hrs following first infusion). Jugular vein blood
draws for further serum progesterone analysis were also taken every 3 hrs for the first 24 hrs, and
every 6 hrs until time of ovariectomy, using the same methodology as in the baseline assessment.
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Quantification of Luteal Blood
Flow
To quantify the influence of fish meal supplementation on luteal blood flow following
low dose intra-uterine infusions of Dinaprost, we measured the changes in luteal blood coverage
from the ultrasound scans. All luteal scans were stored in CINELOOP files and were converted
to AVI files on the ExaPad mini. Files were then transported to a computer, wherein ImageJ
(Fiji: version 2.6.0) was used for further analysis. The analyzer was blinded to all file names
(including cow number) to reduce bias. The AVI files were selectively reduced to frames that
contained minimal artifact and a full luteal scan (from apex to base of the CL). Artifact was
defined as red spots appearing and disappearing within a single or double frame. Any uncertainty
in artifact exclusions were secondarily assessed by an additional trained professional. Thereafter,
pixel length was converted to cm (analyze>set measurement) using the provided scale on each
ultrasound image. The maximal diameter of the gland was determined using the measure
function (analyze>measure) on the identical and adjacent B-mode image to ensure accuracy of
the measurement, as red coloration tended to conceal the outer limit of the CL. The entire gland
was then circled using the “polygon selections” tool (figure 2.2A). The circle drawn around the
outline of the CL (region of interest; ROI) was then manually moved over to the power mode
image, identical to how it was placed on B mode. In doing so, we ensured consistency when
determining the ROI, as we only accounted for intra-luteal blood flow. The circled area was then
duplicated (figure 2.2B) and converted to grey scale (Image>adjust>color threshold), wherein all
red pixels were converted to black, and all non-red pixels were converted to white (threshold
color B&W; figure 2.2C-D). The hue of the color threshold was set to 1, saturation set to 1 and
thresholding method set to default (figure 2.2D). With the gland still outlined, the percentage of
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total black pixels was quantified using the color pixel counter plugin (plugins>color pixel
counter; plugin:color:color_pixel_counter:start; figure 2.2E).
Data Analysis. The “% colored pixels” (percent non-colored pixels) was then subtracted
from 1 to determine percent of black pixilation (100-% colored pixels). The same processes were
repeated from frame to frame, until the glandular diameter was 10% of the maximal diameter.
The maximal percentage of blood coverage falling within the 10% window was reported as the
CL blood flow for the animal at said timepoint.
Statistical Analysis. With a sample size of 30, assessment of normality was not required
nor performed. A PROC MIXED model with repeated measures was used to determine overall
effects, as previously outlined. An autoregressive covariance structure was used in the repeated
measures model, consistent with the previously mentioned. Variables assessed included cow,
time of scan, supplementation, infusion, CL functionality and all possible interactions. If main
effects of interactions were significant (p<0.05), a preplanned pairwise t-test comparisons
analysis was used with the PDIFF function to determine statistical differences between groups.
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Figure 2.2
Quantifying Luteal Blood Flow From Ultrasonography Scans Using ImageJ Software
0.3 cm/s

A

Power mode

B mode

60 mm

C

B

D

E
Note. A) Representative power Doppler ultrasound image of the corpus luteum (CL) and
associated blood flow on the left, and B mode of same scan to demonstrate CL boundaries.
Region of interest (ROI) was outlined in yellow. Settings used for all ultrasound scans were as
follows; frequency 6 MHz, PFR 2000 Hz, wall filter 2, gain 18, and depth 60 mm. Blood flow
was only captured in vessels with flow slower than 0.3 cm/s. Range of speeds per pixel is
indicated by color of pixel; black=0 cm/s, white= 0.3 cm/s (left color bar). B) The ROI was then
duplicated. C-D) The duplicated RIO was color threshold adjusted to black and white (B&W),
hue set to 1, saturation set to 1, and thresholding method set at default. E) Using the color pixel
counter plugin, the percentage of colored pixels (white) compared to black pixels was compared.
The percentage of blood flow was quantified by subtracting the % color value from 100 (100-%
color).
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Serum Progesterone Extraction
and Quantification
Prior to the quantification of serum progesterone, to remove any progesterone bound to
carrier molecules, a double organic phase extraction was performed. Stored serum samples were
first thawed at room temperature. A total of 100 uL of serum was added to a 13 X 100 disposable
Borosilicate glass tube, followed by the addition of 1 mL of petroleum ether, performed in a
fume hood. The tubes and contents were vortexed for 1 min to allow for complete extraction of
the upper organic phase (containing progesterone) from the lower inorganic phase (containing
aqueous binding proteins). Thereafter, tubes were placed in a -80oC freezer for 15-20 mins, or
until solidification of the aqueous phase. The organic phase was then decanted into a new set of
clean glass tubes. Tubes were then placed in a 42oC heat block, and the petroleum ether was
further evaporated with nitrogen gas. The process was repeated one more time with the original
(thawed) aqueous phase. The dried, double extracted samples were reconstituted in 1.5 mL of
Elisa buffer, which was provided in the Cayman Chemical Progesterone ELISA Kit (582601).
Samples were vortexed, covered with parafilm, and left to incubate at 4oC overnight to ensure
complete reconstitution of progesterone into the buffer. The following day, the Progesterone
ELISA Kit was used to quantify the concentration of progesterone in serum, as per the manual
provided by Cayman Chemical. Briefly, all samples were run in duplicate, and an additional
control was run with all samples to quantify the assay coefficient of variation
𝑆𝑡𝑎𝑛𝑑𝑎𝑟𝑑 𝑑𝑒𝑣𝑖𝑎𝑡𝑖𝑜𝑛

(

𝑚𝑒𝑎𝑛

𝑋 100). All samples were measured at 412 nm on a SpectraMax® 190

Absorbance Microplate Reader (Molecular Devices).
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Data Analysis. A CL was defined as functional if the cows’ blood progesterone was
maintained above 1 ng/ mL at time of ovariectomy (30 or 40 hrs following first infusion).
The ratio of functional CL was defined as (

#𝑓𝑢𝑛𝑐𝑡𝑖𝑜𝑛𝑎𝑙 𝐶𝐿
#𝑡𝑜𝑡𝑎𝑙 𝐶𝐿

𝑋 100).

Statistical Analysis. With a sample size greater than 30, assessment of normality was not
required nor performed. A PROC MIXED with repeated measures was used to determine main
effects, as previously outlined. An autoregressive covariance structure was used in the repeated
measures model, as previously defined. Variables included in the model were cow, hour of blood
draw, supplementation, infusion group and all possible interactions. If main effects of
interactions were significant (p<0.05), a preplanned pairwise t-test comparisons analysis was
used with the PDIFF function to determine statistical differences between groups. When
determining statistical differences of functional CL between supplementation groups, a chisquared test was utilized.
Ovariectomies and Luteal Tissue
Preparation
Cows were then prepared for standing flank single ovariectomies (surgery) 48 hrs
following the first infusion. Prior to surgery, cows were held from feed for 24 hrs and water for
12 hrs. Immediately before surgery, cows were administered 650 mg of Flunixin Meglumine
(Mereck NADA 101-479) I.V. and 9900 mg of Noromycin 300 LA Oxytetracycline (Norbrooks
Labs NADA 141-143) I.M. Next, a 60 cm X 60 cm square was shaved in and around the
paralumbar fossa with shears, and thoroughly cleaned with 70% ethanol and betadine. Cows
were then locally anesthetized in an inverted-L infiltration pattern (targeting the T13-L5 vertebra
nerve plexus) with 4% subdermal Lidocaine (VetOne NDC 13985-222-04) injections. Following
the confirmation of a successful nerve block, a sterile surgical drape was placed across the cow
to maintain a clean incision site, and a 30 cm X 30 cm hole was incised into the drape. Next, a

62
lateral 20 cm incision was made through the integument of the cow with a surgical blade. All
abdominal muscles were bluntly dissected in the direction of muscle striation to avoid excessive
bleeding, and a small incision was made in the peritoneum. The ovary was then located, and
blood supply was clamped off at the ovarian peduncle with an umbilical cord clamp. The ovary
was removed from the mesovarium using surgical scissors. Upon removal of the ovary from the
cow, the CL was dissected from the ovarian cortex, weighed, measured, and photographed.
Following removal of the ovary, the peritoneum and abdominal muscles were sutured closed
with #3 Catgut (Jorgensen Laboratories J0091C20), using a continuous suture pattern. The
integument was further sutured closed with #2 Braunamid Suture (Jorgensen Laboratories
JOR0091030) using a continuous cross stitch pattern.
Every 24 hrs, and for three days post-surgery, cows were administered 650 mg of
Flunixin Meglumine IV, rectal temperatures were recorder for monitoring of infection, and
sutures were examined for inflammation or infection. Sutures were removed two weeks
following surgery.
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CHAPTER III
RESULTS
The Influence of Docosahexaenoic Acid and Eicosapentaenoic Acid
on Tumor Necrosis Factor Alpha and Interferon GammaInduced Cytotoxicity on Bovine Luteal Cells
Steroidogenic Cell Population in
Culture
A nitro tetrazolium blue assay was used to estimate the percentage of steroidogenic cells
at 1, 7 and 11 days of culture. There was a main effect of stage of CL on percentage of
steroidogenic cells. The percentage of steroidogenic cells isolated from early (day 1-5 of the
estrous cycle [EC]; n=4), middle (day 6-12 of the EC; n=6) or late (day 13-17 of the EC; n=5)
did not differ at 1 or 7 days of culture (p>0.05; figure 3.1A). However, there was a greater
decrease in percentage of steroidogenic cells at 11 days of culture for tissue obtained from early
and mid CL as compared to cells obtained from late CL.
There was a main effect of time on percentage of steroidogenic cells. When comparing
the percentage of steroidogenic cells over time in culture within early staged cells, populations
did not significantly differ (p<0.05) until day 11 in culture (figure 3.1B), indicating experiments
should not proceed longer than 7 days. The percentage of steroidogenic cells in middle staged
cells significantly decreased (p<0.05) from day 1, 7, and 11 in culture (figure 3.1C). These
results indicate that the population of phenotypically conserved steroidogenic cells was not
consistent by the end of experiments in middle staged cells. In late staged cells, the steroidogenic
population was maintained until day 7 in culture, followed by a significant decreased (p<0.05) at
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day 11 compared to day 1 (figure 3.1D), meaning steroidogenic cells were most likely preserved
in experiments. Although late-stage cells maintain a greater steroidogenic phenotype by day 11
in culture compared to the early and middle staged cells, the relative percentage (within stage)
significantly declines over time, like the other two stages.
Figure 3.1
3 Beta-Hydroxysteroid Dehydrogenases (3βHSD) Positive Steroidogenic Cell Populations
Declined 11 Days in Culture Following Enzymatic Digest
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Note. Corpora lutea (CL) were first staged as early: days 1-5 of the estrous cycle (EC; n=4),
middle: days 6-12 of the EC (n=6), or late: days 13-17 of the EC (n=5). Following CL staging
and enzymatic digest, cells were plated and cultured for 1, 7, or 11 days. The percentage of
steroidogenic luteal cells was determined using a nitro tetrazolium blue (NTT) assay, wherein
cells containing active 3βHSD convert NTT (and so cells) to a dark blue color. Letters (a, b, c)
indicate statistically significant differences (P<0.05) within day and between stage (A) and
within stage between days (B-D). Data are presented as mean ± SEM.
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The Cytotoxicity of Tumor Necrosis
Factor Alpha and Interferon
Gamma on Differentially
Staged Bovine Luteal
Cells
Cells isolated from early (n=5), middle (n=5), or late (n=10) CL were exposed to tumor
necrosis factor alpha (TNFα) and interferon gamma (IFNγ) for 0 to 48 hrs to investigate the
influence of CL stage on cytokine cytotoxicity. Cells obtained from middle stage CL were more
viable (p<0.05) 48 hrs following exposure to cytokines when compared to cells obtained from
early and late staged CL (figure 3.2).
Figure 3.2
Mixed Bovine Luteal Cells of a Middle-Staged Corpus Luteum (CL) Were Less Sensitive to the
Cytotoxic Effects of Tumor Necrosis Factor Alpha (TNFα) and Interferon Gamma (IFNγ)
Exposure
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Note. Cells were exposed to 2.3 nM TNFα and 2.5 nM IFNγ for 0, 12, 24, 36, or 48 hrs. An
adenosine 5-triphosphate luminescence assay was utilized to assess cellular viability, and all
values were normalized to untreated controls. Early= cells from CL isolated between days 1-5 of
the estrous cycle (EC; n=5). Middle= days 6-12 of the EC (n=5). Late=days 13-17 of the EC
(n=10). Differences in letters (a, b) indicate significant differences (p<0.05) between stages
within time following TNFα and IFNγ exposure. Data are presented as mean ± SEM.
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Eicosapentaenoic Acid and Docosahexaenoic Acid
Pre-Treatment on Tumor Necrosis Factor Alpha
and Interferon Gamma Induced Cytotoxicity
Cells isolated from early (n=5), middle (n=5), and late CL (n=10) were pre-treated with
eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA) to determine the influence of
omega-3 fatty acids on the cytotoxic effects (relative viability) of tumor necrosis factor alpha
(TNFα) and interferon gamma (IFNγ). Cellular viability in early staged cultures did not differ
(p>0.05) between bovine serum albumin controls (BSA Cont) and EPA and DHA pre-treated
controls (ω-3 Cont) 12, 24, 36, or 48 hrs of culture (figure 3.3A-D). Cells exposed to TNFα and
IFNγ (BSA TI and ω -3 TI) underwent a significant reduction (p<0.05) in relative viability
(compared to controls) at all time points (Figure 3.3A-D). BSA TI and ω -3 TI groups did not
significantly differ (p>0.05) in relative viability (Figure 3.3A-D). Cellular viability was identical
for middle staged cells 12-, 24-, and 36-hrs following cytokine exposure (figure 3.4A-C).
However, cellular viability was significantly increased (p<0.05) in the ω -3 Cont when compared
to the BSA Cont, indicating that in middle stage cells, DHA and EPA may increase relative
viability 48 hrs following pre-treatment (figure 3.4D). Viability in late staged cells were like that
of early staged cells, in that no significant difference (p>0.05) occurred between controls (BSA
Cont and ω -3 Cont), nor between cells exposed to TNFα and IFNγ with different pre-treatment
groups (BSA TI and ω -3 TI: figure 3.5A-D). Likewise, cellular viability between unexposed
controls (BSA Cont and ω -3 Cont) did not significantly differ (p>0.05) between TNFα and IFNγ
exposed cells (BSA TI and ω -3 TI).
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Figure 3.3
Eicosapentaenoic Acid (EPA) and Docosahexaenoic Acid (DHA) Pre-Treatment Did Not Protect
Luteal Cells Isolated From an Early-Staged Corpus Luteum (CL) From the Cytotoxic Effects of
Tumor Necrosis Factor Alpha (TNFα) and Interferon Gamma (IFNγ)
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Note. Cells were pre-treated with 10 uM DHA and 10 uM EPA for 72 hrs. Cells were then
exposed to 2.3 nM TNFα & 2.5 nM IFNγ for 12 (A), 24 (B), 36 (C), or 48 hrs (D). An adenosine
5-triphosphate luminescence assay was utilized to assess cellular viability, and all values were
normalized to BSA controls. Early-stage CL= isolated between days 1-5 of the estrous cycle
(n=5 CL). BSA Cont= bovine serum albumin control; BSA TI= BSA and TNFα & IFNγ
exposure; ω-3 Cont= DHA & EPA control; ω-3 TI= DHA & EPA and TNFα & IFNγ. A-D)
Differences in letters (a, b) indicate statistical differences (P<0.05) between treatment groups.
Data are presented as mean  SEM.
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Figure 3.4
Eicosapentaenoic Acid (EPA) and Docosahexaenoic Acid (DHA) Pre-Treatment Did Not Protect
Luteal Cells Isolated From a Middle-Staged Corpus Luteum (CL) From the Cytotoxic Effects of
Tumor Necrosis Factor Alpha (TNFα) and Interferon Gamma (IFNγ)
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Note. Cells were pre-treated with 10 uM DHA and 10 uM EPA for 72 hrs. Cells were then
exposed to 2.3 nM TNFα & 2.5 nM IFNγ for 12 (A), 24 (B), 36 (C), or 48 hrs (D). An adenosine
5-triphosphate luminescence assay was utilized to assess cellular viability, and all values were
normalized to BSA controls. Middle-stage CL= isolated between days 6-12 of the estrous cycle
(n=5 CL). BSA cont= bovine serum albumin control; BSA Cont= bovine serum albumin control;
BSA TI= BSA and TNFα & IFNγ exposure; ω-3 Cont= DHA & EPA control; ω-3 TI= DHA &
EPA and TNFα & IFNγ. A-D) Differences in letters (a, b, c) indicate statistical differences
(P<0.05) between treatment groups. Data are presented as mean  SEM.
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Figure 3.5
Eicosapentaenoic Acid (EPA) and Docosahexaenoic Acid (DHA) Pre-Treatment Did Not Protect
Luteal Cells Isolated From a Late-Staged Corpus Luteum (CL) From the Cytotoxic Effects of
Tumor Necrosis Factor Alpha (TNFα) and Interferon Gamma (IFNγ)
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Note. Cells were pre-treated with 10 uM DHA and 10 uM EPA for 72 hrs. Cells were then
exposed to 2.3 nM TNFα & 2.5 nM IFNγ for 12 (A), 24 (B), 36 (C), or 48 hrs (D). An adenosine
5-triphosphate luminescence assay was utilized to assess cellular viability, and all values were
normalized to BSA controls. Late-stage CL= isolated between days 13-17 of the estrous cycle
(n=10). BSA cont= bovine serum albumin control; BSA Cont= bovine serum albumin control;
BSA TI= BSA and TNFα & IFNγ exposure; ω-3 Cont= DHA & EPA control; ω-3 TI= DHA &
EPA and TNFα & IFNγ. Differences in letters (a, b) indicate statistical differences (P<0.05)
between treatment groups. Data are presented as mean  SEM.
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Apoptotic Gene Expression
Mixed bovine luteal cells isolated from early (n=4), middle (n=5), or late (n=5) CL were
pre-treated with eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA) to determine the
influence of omega-3 fatty acids on apoptotic gene expression following tumor necrosis factor
alpha (TNFα) and interferon gamma (IFNγ) exposure. No significant differences (p>0.05) or
trends (p>0.1) between BAX or BCL2 were observed in early staged cultures, regardless of
treatment (figure 3.6A, figure 3.6C). There was, however, a statistical increase in CASP3
expression between the BSA Cont and BSA TI groups, indicating TNFα and IFNγ exposure
increased expression of a pro-apoptotic gene (figure 3.6B). Furthermore, cells within the ω -3
Cont had a higher expression (trend; p<0.1) of CASP3 when compared to the BSA Cont,
indicating EPA and DHA regulate transcriptional control of the apoptotic pathway, independent
of external stimuli in the early CL. However, the effect of EPA and DHA pre-treatment did not
appear to predispose cells for elevated CASP3 expression following TNFα and IFNγ exposure, as
BSA TI and ω -3 TI groups did not significantly differ (p>0.05). Within middle staged cultures,
the only trends (p<0.1) observed were increased expression of BAX and CASP3 in the BSA TI
group when compared to the BSA control, indicating exposure to TNFα and IFNɣ, but not EPA
and DHA pre-treatment, increase apoptotic gene expression (figure 3.6D, figure 3.6E). Gene
expression for BCL2 did not significantly differ (p>0.05) and no trends were observed (p>0.1;
Figure 3.6F), indicating neither EPA and DHA pre-treatment or TNFα and IFNɣ exposure
influenced BCL2 expression in middle staged cultures. Late staged cultures exposed to TNFα
and IFNɣ had a significant increase (p<0.5; BSA TI) in BAX expression compared to the BSA
Cont, independent of EPA and DHA pre-treatment (p>0.5; figure 3.6G). CASP3 expression was
significantly elevated (p<0.05; ω -3 Cont) and trended towards elevation (p<0.1; BSA TI)
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following TNFα and IFNɣ exposure, independent of EPA and DHA pre-treatment as neither
BSA Cont vs. ω -3 Cont nor BSA TI vs. ω -3 TI significantly differed (p>0.05; figure 3.6H).
Consistent with early and middle staged cultures, late cultures had no significant changes (p>0.5)
or trends (p>0.1) in BCL2 expression between groups (figure 3.6I).
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Figure 3.6
Eicosapentaenoic Acid (EPA) and Docosahexaenoic Acid (DHA) Pre-Treatment Altered Apoptotic Gene Expression in Cells From Early-Staged Corpora Lutea (CL), but Not Those of a Middle or Late-Staged CL Following Exposure to Tumor Necrosis
Factor Alpha (TNFα) and Interferon Gamma (IFNɣ)
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Note. Cells were pre-treated with 10 uM EPA and 10 uM DHA for 72 hrs, and subsequently exposed to 2.3 nM TNFα and 2.5 nM IFNɣ for 24 hrs. The deltadelta Ct method (2-Ct) was used when analyzing fold change of steady state mRNA. A-C) Cells
isolated from early staged CL= day 1-5 of the estrous cycle (EC; n=4), D-F) Cells isolated from middle staged CL= day 6-12 of the EC (n=5). G-I) Cells isolated from late staged CL= day 13-17 of the EC (n=5). BSA Cont= bovine serum albumin control;
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as mean  SEM.
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Necroptotic Gene Expression
Mixed bovine luteal cells isolated from early (n=4), middle (n=5), or late (n=5) CL were
pre-treated with EPA and DHA to determine the influence of omega-3 fatty acids on necroptotic
gene expression following TNFα and IFNɣ exposure. Within early staged cultures, only cells
from the ω -3 TI group had significantly elevated expression of RIPK1 (p<0.05; figure 3.7A).
However, because the BSA TI and the ω-3 TI did not statistically differ, it cannot be concluded
that EPA and DHA pre-treatment differentially influenced the expression of RIPK1. RIPK3 gene
expression was significantly increased (p<0.05) following TNFα and IFNɣ exposure and was not
differentially influenced by EPA and DHA pre-treatment (figure 3.7B). MLKL gene expression
was elevated in both BSA TI, and ω-3 TI groups compared to controls, however, ω-3 TI was
significantly lower (p<0.05) when compared to BSA TI (figure 3.7C). These results partially
support the hypothesis that EPA and DHA pre-treatment reduce necroptotic gene expression
following exposure to TNFα and IFNɣ in the early phase CL. Middle staged cultures exposed to
TNFα and IFNɣ had increased expression (p<0.05) of RIPK1 (ω-3 TI; figure 3.7D) and RIPK3
(ω-3 TI and BSA TI; figure 3.7E). However, elevation in gene expression within both genes was
independent of EPA and DHA pre-treatment due to an insignificant difference (p>0.05) between
BSA TI and ω-3 TI groups. MLKL was significantly lower (p<0.05) in the ω-3 Cont cultures
compared to the BSA Cont, indicating that EPA and DHA pre-treatment may reduce basal
transcriptional activation of MLKL (figure 3.7F). However, the reduction in gene expression was
not observed following TNFα and IFNɣ exposure; MLKL expression was significantly elevated
(p<0.05) following TNFα and IFNɣ exposure in both BSA TI and ω-3 TI groups, and expression
between groups did not significantly differ (p>0.05). Cells from late staged cultures had no
significant difference (p>0.05) in expression of RIPK1 (figure 3.7G). RIPK3 expression trended
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towards significant elevation (p<0.1; ω-3 TI) following TNFα and IFNɣ but did not significantly
differ (p>0.05) nor trend different (p>0.1) between BSA TI and ω-3 TI groups, indicating
changes in gene expression were independent of EPA and DHA pre-treatment (figure 3.7H).
MLKL expression was significantly elevated (p<0.05) in both BSA TI and ω-3 TI groups but did
not significantly differ (p>0.05) between groups, indicating MLKL expression was independent
of EPA and DHA pre-treatment (figure 3.7I).
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Figure 3.7
Eicosapentaenoic Acid (EPA) and Docosahexaenoic Acid (DHA) Pre-Treatment Altered Necroptotic Gene Expression in Cells From Early and Middle Staged Corpora Lutea (CL), but Not Those of a Late-Staged CL Following Exposure to Tumor
Necrosis Factor Alpha (TNFα) and Interferon Gamma (IFNɣ)
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Note. Cells were pre-treated with 10 uM EPA and 10 uM DHA for 72 hrs, and subsequently exposed to 2.3 nM TNFα and 2.5 nM IFNγ for 24 hrs. The delta delta Ct method (2-Ct) was used when analyzing fold change of steady state mRNA. A-C) Cells
isolated from early staged CL= day 1-5 of the estrous cycle (EC; n=4). D-F) Cells isolated from middle staged CL= day 6-12 of the EC (n=5). G-I) Cells isolated from late staged CL= day 13-17 of the EC (n=5). BSA Cont= bovine serum albumin control;
BSA TI= BSA and TNFα & IFNγ exposure; ω-3 Cont= DHA & EPA control; ω-3 TI= DHA & EPA and TNFα & IFNγ. *Significant difference (p<0.05) between treatments. p values were reported if p<0.1, indicating statistical trend. Data are presented
as mean  SEM.
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Programed Cell Death Related
Gene Expression
Mixed bovine luteal cells isolated from early (n=4), middle (n=5), or late (n=5) CL were
pre-treated with EPA and DHA to determine the influence of omega-3 fatty acids on cell death
related genes following TNFα and IFNɣ exposure. Cells from early staged cultures exposed to
TNFα and IFNγ had a significant increase (p<0.05) in TNFR1 (figure 3.8A), TNFα (figure 3.8B),
and NF𝜅B (figure 3.8C) expression. However, as both BSA TI and ω-3 TI groups did not
significantly differ (p>0.05), expression pattern of all genes was independent of EPA and DHA
pre-treatment. No significant changes (p>0.05) nor trended towards differences (p>0.1) were
detected in TNFR1 gene expression between groups of a middle CL (figure 3.8D). This indicates
TNFR1 expression may be differentially regulated in a middle CL. However, it is important to
note the variation as a potentially confounding source. TNFα expression was significantly
elevated (p<0.05) following TNFα and IFNγ exposure in the ω-3 TI group (figure 3.8E).
Although the BSA TI groups did not significantly differ from controls (p<0.05), results also did
not differ from the ω-3 TI group, suggesting the elevated expression is not a result of the EPA
and DHA pre-treatment. NF𝜅B gene expression was significantly elevated (p<0.05) in both the
BSA TI and the ω-3 TI groups, but because expression did not significantly differ (p>0.05)
between groups, results are not due to EPA and DHA pre-treatment (figure 3.8F). Within late
staged cultures, TNFR1 (figure 3.8G), TNFα (figure 3.8H), and NF𝜅B (figure 3.8I) were all
significantly elevated (p<0.05) in BSA TI and ω-3 TI groups, but not between groups (p>0.05),
indicating changes were independent of EPA and DHA pre-treatment.
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Figure 3.8
Eicosapentaenoic Acid (EPA) and Docosahexaenoic Acid (DHA) Pre-Treatment Did Not Differentially Alter Programmed Cell-Death Associated Gene Expression in Cells From Early, Middle, or Late-Staged Corpora Lutea (CL) Following Expos ure to
Tumor Necrosis Factor Alpha (TNFα) and Interferon Gamma (IFNɣ)
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Note. Cells were pre-treated with 10 uM EPA and 10 uM DHA for 72 hrs, and subsequently exposed to 2.3 nM TNFα and 2.5n M IFNγ for 24 hrs. The delta delta Ct method (2-Ct) was used when analyzing fold change of steady state mRNA. A-C) Cells
isolated from early staged CL= day 1-5 of the estrous cycle (EC; n=4). D-F) Cells isolated from middle staged CL= day 6-12 of the EC (n=5). G-I) Cells isolated from late staged CL= day 13-17 of the EC (n=5). BSA Cont= bovine serum albumin control;
BSA TI= BSA and TNFα & IFNγ exposure; ω-3 Cont= DHA & EPA control; ω-3 TI= DHA & EPA and TNFα & IFNγ. *Significant difference (p<0.05) between treatments. p values were reported if p<0.1, indicating statistical trend. Data are presented
as mean  SEM.
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Steroidogenic Gene Expression
Mixed bovine luteal cells isolated from early (n=4), middle (n=5), or late (n=5) CL were
pre-treated with EPA and DHA to determine the influence of omega-3 fatty acids on
steroidogenic genes following TNFα and IFNɣ exposure. Early staged cultures exposed to TNFα
and IFNɣ underwent a significant decrease (p<0.05; BSA TI) and trended towards a decrease
(p<0.1; ω-3 TI) in STARD1 gene expression (figure 3.9A). Since no significant difference
(p>0.05) was detected between BSA TI and ω-3 TI groups, the reduction in STARD1 expression
is not equated to EPA and DHA pre-treatment. No significant differences (p>0.05) or trends
(p>0.1) existed with regards to CYP11A1 gene expression (figure 3.9B). Following exposure to
TNFα and IFNɣ, middle staged cultures had a significant reduction (p<0.05; ω-3 TI) in STARD1
gene expression (figure 3.9C). CYP11A1 trended toward decreasing gene expression (p<0.1) in
both BSA TI and ω-3 TI groups (figure 3.9D). Within both STARD1 and CYP11A1, no statistical
difference (p>0.05) occurred between BSA TI, and ω-3 TI treated groups, indicating reduction in
steroidogenic gene expression is solely influenced by TNFα and IFNɣ exposure. In late staged
cultures, cells exposed to TNFα and IFNɣ had a trending reduction (p<0.1; BSA TI) in STARD1
gene expression (figure 3.9E). Since no statistical difference was found between BSA TI and ω-3
TI, the reduced gene expression was independent of EPA and DHA pre-treatment. CYP11A1
significantly decreased in expression (p<0.05) in both BSA TI and ω-3 TI groups (figure 3.9F).
The overall reduction in steroidogenic gene expression following TNFα and IFNɣ
supports the hypothesis that the cytokines reduce steroidogenic mRNA transcripts. Moreover, the
hypothesis that EPA and DHA pre-treatment would maintain steroidogenic gene expression
following TNFα and IFNɣ exposure was rejected.
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Figure 3.9
Eicosapentaenoic Acid (EPA) and Docosahexaenoic Acid (DHA) Pre-Treatment Did Not Differentially Alter Steroidogenic Gene Expression in Cells from Early, Middle, or Late-Staged Corpora Lutea (CL) Following Exposure to Tumor Necrosis Factor
Alpha (TNFα) and Interferon Gamma (IFNɣ)
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Note. Cells were pre-treated with 10 uM EPA and 10 uM DHA for 72 hrs, and subsequently exposed to 2.3 nM TNFα and 2.5 nM IFNγ for 24 hrs. The delta delta Ct method 3(2-Ct) was used when analyzing fold change of steady state mRNA. A-B) Cells
isolated from early staged CL= day 1-5 of the estrous cycle (EC; n=4). C-D) Cells isolated from middle staged CL= day 6-12 of the EC (n=5). E-F) Cells isolated from late staged CL= day 13-17 of the EC (n=5). BSA Cont= bovine serum albumin
control; BSA TI= BSA and TNFα & IFNγ exposure; ω-3 Cont= DHA & EPA control; ω-3 TI= DHA & EPA and TNFα & IFNγ. *Significant difference (p<0.05) between treatments. P values were reported if p<0.1, indicating statistical trend. Data are
presented as mean  SEM.
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Gene Expression Across Stages
Following Cytokine Exposure
We also investigated the influence of luteal stage (early [n=4], middle [n=5], and late
[n=5]) on gene expression following exposure of mixed bovine luteal cells to TNFα and IFNγ.
Changes in gene expression across luteal stages were quantified by generating a ratio of the delta
Ct (2-DCt) values in the BSA TI groups to the 2-DCt in BSA Cont groups (relative gene
expression). No differences (p>0.05) or trends (p>0.1) were observed between luteal stages for
apoptosis associated genes, BAX, CASP3 and BCL2 (Figure 3.10A-C) nor in the steroidogenesis
associate genes, STARD1 and CYP11A1 (Figure 3.10J-K). Interestingly, MLKL in cells isolated
from a late CL had a near significant increase in expression following TNFα and IFNγ when
compared to cells from early staged CL, indicating late CL may be more adept for necroptosis
associated signaling. Moreover, cells isolated from late staged CL trended towards increased
expression of TNFR1 gene expression (figure 3.10G). The two aforementioned results are of
particular interest as necroptotic signaling occurs via activation of the TNFRI.
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Figure 3.10
Apoptosis Associated Genes
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Note. Cells were exposed to 2.3 nM TNFα and 2.5 nM IFNγ for 24 hrs, following which RNA was isolated. The relative expression of apoptotic (A-C), necroptotic (D-F), programmed cell death (G-I), and steroidogenic related genes was reported as ratio
of the delta Ct (2-Ct) of cells exposed to TNFα and IFNγ (BSA TI) to the 2-Ct of cells exposed to BSA alone (BSA Cont). Cells isolated from early staged CL= day 1-5 of the estrous cycle (EC; n=4), middle staged CL= day 6-12 of the EC (n=5), and late
staged CL= day 13-17 of the EC (n=5). P <0.1 indicates strong statistical trend. Data are presented as mean  SEM.
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Fish Meal Supplementation on Luteal Blood Flow
Following Two Low Dose Intra-Uterine Infusions
of Prostaglandin F2 Alpha
Abundance of Plasma Eicosapentaenoic Acid
and Docosahexaenoic Acid in Plasma
Cows were given either corn gluten meal (CM; n=9) or fish meal (FM; n=10) supplement
for 63 days and weekly blood samples were drawn to quantify abundance of EPA and DHA in
the plasma. Blood plasma EPA in FM supplemented cows was significantly more abundant
(p<0.05) by day 7, and until day 63, when compared to CM supplemented cows (figure 3.11A),
indicating EPA from the FM supplementation was successfully incorporated into the blood of
animals. Blood plasma DHA in FM supplemented cows was significantly elevated (p<0.05) by
day 14, and remained elevated by day 63, when compared to CM supplemented cows (figure
3.11B), therein signifying successful incorporation of DHA into blood. Both omega-3 fatty acids
were effectively, and differentially incorporated into blood plasma within two weeks of
supplementation. By the time of the experimental period (directly following day 63 of
supplementation), cows had a significant difference in both EPA and DHA concentrations,
indicating any results of the experimental period could be due to supplementation effects.
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Figure 3.11
Fish Meal (FM) Supplementation Increases the Abundance of Eicosapentaenoic Acid (EPA) and
Docosahexaenoic Acid (DHA) in Blood Plasma When Compared to Corn Gluten Meal (CM)
Supplemented Cows
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Note. Cows were supplemented with either CM (n=9) or FM (n=10) for 63 days, during which
weekly jugular vein blood draws were performed to quantify abundance of EPA (A) and DHA
(B) in the blood plasma. Following plasma separation and subsequent methylation, fatty acid
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abundance was assessed using liquid gas chromatography. *Statistical difference (p<0.05)
between supplementation groups within day. Data are presented as mean  SEM.
Percentage of Functional Corpus
Luteum at Time of Ovariectomy
Following the 63-day supplementation period, cows received two low dose infusions of
either prostaglandin F2 alpha (PGF2α) or saline, 12 hrs apart. Luteal functionality was defined as
serum progesterone >1 ng/mL at time of ovariectomy (30 or 48 hrs following first infusion). As
was expected, cows supplemented with CM or FM and infused with saline (CM-Saline [n=5];
FM-Saline[n=4]) all maintained a functional CL (figure 3.12). Cows supplemented with CM and
that received two PGF2α infusions (CM-PGF2α; n=11) maintained a functional CL 33.3% of the
time, whereas FM supplemented and PGF2α infused (FM-PGF2α n=14) maintained a functional
CL 71.4% of the time, equating to a 114.4% increase in functionality in the FM- PGF2α group
relative to CM-PGF2α. There was a tendency for increased functional CL in FM supplemented
cows (p<0.1). From these results it can be extrapolated that FM supplementation reduces rates of
regression following PGF2α exposure.
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Figure 3.12
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Fish Meal (FM) Supplementation Maintains a Greater Proportion of Functional Corpus Luteum
(CL) Following Two Low Dose Intra-Uterine Infusions of Prostaglandin F2 Alpha (PGF2α),
When Compared to Corn Gluten Meal (CM) Supplemented Cows
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Note. Cows were supplemented with either CM or FM for 63 days, during which estrus were
synchronized. On day 10-12 following onset of estrus, cows were infused with either 0.25mL
saline or 0.5mg of PGF2α (in 0.25 mL saline) in the uterine horn ipsilateral to the CL-bearing
ovary. The cows were infused twice, each infusion 12 hrs apart. Jugular vein blood draws were
performed, and serum progesterone concentrations later quantified using a progesterone ELISA.
CL were defined as functional if serum progesterone > 1 ng/mL or regressed if <1 ng/mL at time
of ovariectomy (30 or 48 hrs following first infusion). CM-Saline (n=5); FM- Saline (n=4); CMPGF2α (n=11); FM-PGF2α (n=14). Statistical significance p<0.05.
Serum Progesterone Following Low
Dose Infusions of Prostaglandin F2
Alpha
Single infusions of either PGF2α or saline occurred at hour 0 and 12. As previously
stated, if serum progesterone was >1 ng/mL the CL was defined as functional and if < 1 ng/mL,
regressed. All groups within CM supplemented cows (infusion groups and functional state of
CL) are shown in figure 3.13A, and all groups within FM supplementation groups in figure
3.13E. When comparing means of CM-Saline (n=5) and CM-PGF2α-Regressed cows (n=7;
figure 3.13B), serum progesterone was significantly lower (p<0.05) at all time points. CMPGF2α Regressed cows declined below the functional threshold (serum progesterone <1ng/mL)
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42 hrs following the first infusion. When comparing means of CM-Saline and CM-PGF2α
Functional groups (n=4; figure 3.13C), only 3 time points (3 hrs, 15 hrs, and 36 hrs) were
significantly lower (p<0.05) in the CM- PGF2α Functional group, but at all time points,
progesterone concentrations were lower than the saline control, indicating PGF2α exposure
reduced progesterone output. Interestingly, CM Functional cows only had a significant
difference in serum progesterone 48 hrs following infusion (figure 3.13D). When comparing the
means of FM-Saline (n=4) and FM-PGF2α Regressed cows (n=4; figure 3.13F), serum
progesterone was significantly lower (p<0.05) at all time points, except for at 3 hrs post infusion.
Moreover, the concentration of progesterone in FM-PGF2α Regressed cows declined below 1
ng/mL at 42 hrs post infusion, like the CM-PGF2α Regressed group. When comparing
concentration means of FM-Saline and FM-PGF2α Functional cows (n=10; figure 3.13G), the
latter had a significantly lower (p<0.05) concentration of progesterone, except at 3-, 9-, and 12hrs following the first infusion, indicating glandular exposure to PGF2α reduced progesterone
output. Serum progesterone in the FM-PGF2α Regressed cows began to significantly decline by
12 hrs post infusion when compared to FM-PGF2α Functional cows, and only FM-PGF2α
Functional cows underwent a rebound in serum progesterone by 21 hrs post infusion (figure
3.13H). Between the CM-Saline and FM-group, progesterone concentrations were significantly
higher (p<0.05) in FM-Saline cows at 21-, 30-, and 48-hrs following the first infusion, indicating
the overall basal progesterone concentrations were not influenced by supplementation group
(figure 3.13 I). Between CM- and FM- PGF2α regressed cows, no significant differences
(p>0.05) were detected at any time point (figure 3.13J), indicating supplementation does not
influence progesterone output in regressing CL. Within both supplementation groups, blood
progesterone steadily declined over the 48-hour experimental period. When CM- and FM-
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PGF2α Functional cows were compared, no significant differences (p>0.05) were detected at any
time point (figure 3.13K). However, both groups had a rebound in progesterone concentrations
3- to 6- hrs following the first infusion, a decrease after the second infusion (at 12 hrs), and
eventually a plateau in progesterone concentrations. The ability of a CL to rebound its output of
serum progesterone appears to be a distinguishing factor between a regressing and functional CL.
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Figure 3.13
Supplementation Group (Corn Gluten Meal [CM] or Fish Meal [FM]) Did Not Differentially Alter Progesterone Concentrations Following Two Low Dose Intra-Uterine Infusions of Prostaglandin F2 Alpha (PGF2α)
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Note. Cows were supplemented with either CM or FM for 63 days, during which estrus was synchronized. On day 10-12 following onset of estrus, cows were infused with either 0.25 mL saline or 0.5 mg of PGF2α (in 0.25 mL saline) in the uterine horn
ipsilateral to the CL-bearing ovary. The cows were infused twice, each infusion 12 hrs apart. Jugular vein blood draws were collected every 3 hrs for the first 24 hrs, and every 6 hrs, until time of ovariectomy (48h following first infusion). Serum
progesterone concentrations were then quantified using a progesterone ELISA. Black line on graphs was set at 1 ng/mL to indicate functional CL threshold. CL were deemed regressed if serum progesterone <1 ng/mL. All CM interactions (A-D), FM
interactions (E-H), and CM versus FM interactions (I-K) between saline or PGF2α infused groups. CM-Saline (n=5); CM-PGF2α Regressed (n=7); CM-PGF2α Functional (n=4); FM-Saline (n=5); FM-PGF2α Regressed (n=4); FM-PGF2α Functional
(n=10). *Significant differences between supplementation or infusion group within time of blood draw. Data are presented as mean ± SEM. Note: overlapping error bars were removed for effective visualization purposes.
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Representative Ultrasound Images
of Luteal Blood Flow Following
Infusions
To assess the influence of CM and FM supplementation on luteal blood flow following
the two low dose intra-uterine infusions of PGF2𝛼, power Doppler ultrasound scans were taken
before and after time of infusion every 15 mins for an hour, and every hour thereafter for 6 hrs.
A final scan was taken at 48 hrs post infusion. Representative images from each group (CMSaline [Figure 3.14]; CM-PGF2α-Regressed [Figure 3.15]; CM=PGF2α-Functional [Figure
3.16]; FM-Saline [figure 3.17]; FM-PGF2α Regressed [figure 3.18]; FM-PGF2α Functional
[figure 3.19]) and repeated scan times for the first infusion (pre infusion/-15 mins [A]; 30 mins
post infusion [B]; 45 mins post infusion [C], 1 hr post infusion [D]) and second infusion (pre
infusion/-15 mins [E]; 30 mins post infusion [F]; 45 mins post infusion [G], 1 hr post infusion
[H], 48 hrs post infusion [F])
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Figure 3.14
Representative Power Doppler Ultrasound Images of Luteal Blood Flow in Corn Gluten Meal
(CM) Supplemented, and Saline Infused Cows

Note. Cows were given CM supplement for 63 days, during which estrus was synchronized. On
day 10-12 following onset of estrus, cows were infused with 0.25mL saline in the uterine horn
ipsilateral to the CL-bearing ovary. Luteal blood flow was assessed using trans-rectal power
Doppler ultrasonography (Frequency 6 MHz, PFR 2000 Hz, and depth 60 mm) at multiple time
points pre- and post-infusion. Colored pixels within the blue box demonstrate differing speeds of
detected flow (upper left color bar; black=0 cm/s, white= 0.3 cm/s). BF= quantified luteal blood
flow of said image. Representative images of blood flow prior to the first saline infusion (A), 30
mins post (B), 45 mins post (C), and 60 mins post (D). Representative images of blood flow prior
to the second saline infusion (E), 30 mins post (F), 45 mins post (G), and 60 mins post (H). I)
Blood flow 48 hrs following the first infusion.
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Figure 3.15.
Representative Power Doppler Ultrasound Images of Luteal Blood Flow in Corn Gluten Meal
(CM) Supplemented, Prostaglandin F2 Alpha (PGF2α) Infused, and Regressed Corpus Luteum
(CL) Cows

Note. Cows were given CM supplement for 63 days, during which estrus was synchronized. On
day 10-12 following onset of estrus, cows were infused with 0.5mg of PGF2α (in 0.25 mL
saline) in the uterine horn ipsilateral to the CL-bearing ovary. Luteal blood flow was assessed
using trans-rectal power Doppler ultrasonography (Frequency 6 MHz, PFR 2000 Hz, and depth
60 mm) at multiple time points pre- and post-infusion. Colored pixels within the blue box
demonstrate differing speeds of detected flow (upper left color bar; black=0 cm/s, white= 0.3
cm/s). CL were defined as regressed if serum progesterone <1 ng/mL at time of ovariectomy (48
hrs). BF= quantified luteal blood flow of said image. Representative images of blood flow prior
to the first PGF2α infusion (A), 30 mins post (B), 45 mins post (C), and 60 mins post (D).
Representative images of blood flow prior to the second PGF2α infusion (E), 30 mins post (F),
45 mins post (G), and 60 mins post (H). I) Blood flow 48 hrs following the first infusion.
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Figure 3.16
Representative Power Doppler Ultrasound Images of Luteal Blood Flow in Corn Gluten Meal
(CM) Supplemented, Prostaglandin F2 alpha (PGF2α) Infused, and Functional Corpus Luteum
(CL) Cows

Note. Cows were given CM supplement for 63 days, during which estrus was synchronized. On
day 10-12 following onset of estrus, cows were infused with 0.5mg of PGF2α (in 0.25 mL
saline) in the uterine horn ipsilateral to the CL-bearing ovary. Luteal blood flow was assessed
using trans-rectal power Doppler ultrasonography (Frequency 6 MHz, PFR 2000 Hz, and depth
60 mm) at multiple time points pre- and post-infusion. Colored pixels within the blue box
demonstrate differing speeds of detected flow (upper left color bar; black=0 cm/s, white= 0.3
cm/s). CL were defined as functional if serum progesterone >1 ng/mL at time of ovariectomy (48
hrs). BF= quantified luteal blood flow of said image. Representative images of blood flow prior
to the first PGF2α infusion (A), 30 mins post (B), 45 mins post (C), and 60 mins post (D).
Representative images of blood flow prior to the second PGF2α infusion (E), 30 mins post (F),
45 mins post (G), and 60 mins post (H). I) Blood flow 48 hrs following the first infusion.
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Figure 3.17
Representative Power Doppler Ultrasound Images of Luteal Blood Flow in Fish Meal (FM)
Supplemented, and Saline Infused Cows

Note. Cows were given FM supplement for 63 days, during which estrus was synchronized. On
day 10-12 following onset of estrus, cows were infused with 0.25mL saline in the uterine horn
ipsilateral to the CL-bearing ovary. Luteal blood flow was assessed using trans-rectal power
Doppler ultrasonography (Frequency 6 MHz, PFR 2000 Hz, and depth 60 mm) at multiple time
points pre- and post-infusion. Colored pixels within the blue box demonstrate differing speeds of
detected flow (upper left color bar; black=0 cm/s, white= 0.3 cm/s). BF= quantified luteal blood
flow of said image. Representative images of blood flow prior to the first saline infusion (A), 30
mins post (B), 45 mins post (C), and 60 mins post (D). Representative images of blood flow prior
to the second saline infusion (E), 30 mins post (F), 45 mins post (G), and 60 mins post (H). I)
blood flow 48 hrs following the first infusion.
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Figure 3.18
Representative Power Doppler Ultrasound Images of Luteal Blood Flow in Fish Meal (FM)
Supplemented, Prostaglandin F2 Alpha (PGF2α) Infused, and Regressed Corpus Luteum (CL)
Cows

Note. Cows were given FM supplement for 63 days, during which estrus was synchronized. On
day 10-12 following onset of estrus, cows were infused with 0.5mg of PGF2α (in 0.25 mL
saline) in the uterine horn ipsilateral to the CL-bearing ovary. Luteal blood flow was assessed
using trans-rectal power Doppler ultrasonography (Frequency 6 MHz, PFR 2000 Hz, and depth
60 mm) at multiple time points pre- and post-infusion. Colored pixels within the blue box
demonstrate differing speeds of detected flow (upper left color bar; black=0 cm/s, white= 0.3
cm/s). CL were defined as regressed if serum progesterone <1 ng/mL at time of ovariectomy (48
hrs). BF= quantified luteal blood flow of said image. Representative images of blood flow prior
to the first PGF2α infusion (A), 30 mins post (B), 45 mins post (C), and 60 mins post (D).
Representative images of blood flow prior to the second PGF2α infusion (E), 30 mins post (F),
45 mins post (G), and 60 mins post (H). I) Blood flow 48 hrs following the first infusion.
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Figure 3.19
Representative Power Doppler Ultrasound Images of Luteal Blood Flow in Fish Meal
Supplemented, Prostaglandin F2 Alpha (PGF2α) Infused, and Functional Corpus Luteum (CL)
Cows

Notes. Cows were given FM supplement for 63 days, during which estrus was synchronized. On
day 10-12 following onset of estrus, cows were infused with 0.5mg of PGF2α (in 0.25 mL
saline) in the uterine horn ipsilateral to the CL-bearing ovary. Luteal blood flow was assessed
using trans-rectal power Doppler ultrasonography (Frequency 6 MHz, PFR 2000 Hz, and depth
60 mm) at multiple time points pre- and post-infusion. Colored pixels within the orange box
demonstrate differing speeds of detected flow (upper left color bar; black=0 cm/s, white= 0.3
cm/s). CL were defined as functional if serum progesterone >1 ng/mL at time of ovariectomy (48
hrs). BF= quantified luteal blood flow of said image. Representative images of blood flow prior
to the first PGF2α infusion (A), 30 mins post (B), 45 mins post (C), and 60 mins post (D).
Representative images of blood flow prior to the second PGF2α infusion (E), 30 mins post (F),
45 mins post (G), and 60 mins post (H). I) Blood flow 48 hrs following the first infusion.
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Luteal Blood Flow Following
Prostaglandin F2 Alpha
Infusions
First Infusion
Images from the power Doppler ultrasonography CL scans were quantified to generate
numerical values for statistical comparisons. All CM associated groups can be visualized in
figure 3.19A, and all FM associated groups in figure 19E. When comparing CM interactions,
both CM-PGF2𝛼 Regressed (figure 3.20B; n=6) and CM-PGF2α Functional (figure 3.20C; n=4)
cows had a significant spike (p<0.05) in luteal blood flow within 60 (CM-PGF2α Regressed) or
30 mins (CM-PGF2α Functional) following infusions compared to CM-Saline (n=4), indicating
PGF2𝛼 influences luteal blood flow in an acute time span. As early as 2 hrs (CM-PGF2α
Regressed) and 4 hrs (CM-PGF2α Functional) post infusion, luteal blood flow re-stabilized to
match control means. Moreover, while both Regressed and Functional groups underwent an
increase in luteal blood flow post infusion, Functional cows underwent this effect 15 mins earlier
(p<0.05), though more conservatively is due to animal variation and small sample size than to
biological effect. When comparing FM interactions, luteal blood flow did not significantly
differentiate (p>0.05) at any point between the FM- saline (n=3) and PGF2𝛼 Regressed groups
(figure 3.20F; n=4), indicating detectable blood flow was not influenced by PGF2𝛼, unlike in the
CM-PGF2𝛼 Regressed group (relative to respective supplement control). However, the lack of
effect may be due to extensive variability at that time point. Furthermore, FM-PGF2𝛼 Functional
cows (figure 3.20G; n=9) only significantly differed from the FM-Saline control 45 mins
following infusion (p<0.05), and immediately re-stabilized within 15 mins (by 60 mins post
infusion); a much faster recovery when compared to the CM-PGF2𝛼 Functional group.
Interestingly, Regressed and Functional cows had no significant difference (p>0.05; figure
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3.20H) at any time point. Additionally, it can be inferred that supplementation did not affect
basal luteal blood flow, as both CM- and FM-Saline groups had no significant differences
(p>0.05; figure 3.20I). Despite the presence and lack of significant differences between CMPGF2α Regressed vs CM-Saline (figure 3.20B) and FM-PGF2α Regressed vs FM-Saline groups
(figure 3.20F), respectively, no significant differences (p>0.05) were detected between CM- and
FM-PGF2α Regressed groups (figure 3.20J). Within PGF2𝛼 Functional groups, FM
supplementation appeared to have blunted the spike in luteal blood flow that occurred in the CM
supplemented cows, made evident by the significant elevation (p<0.05) in blood flow 30 mins,
60 mins, and 2 hrs following infusion in CM-PGF2𝛼 Functional cows (figure 3.20K).
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Figure 3.20
Fish Meal (FM) Supplemented Cows Had a Blunted Response in Luteal Blood (Percentage of Luteal Blood Flow) When Compared to Corn Gluten Meal (CM) Supplemented Cows Following the First Low Dose Intra-Uterine Infusion of Prostaglandin F2
Alpha (PGF2α)
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Note. Cows were supplemented with either CM or FM for 63 days, during which estrus was synchronized. On day 10-12 following onset of estrus, cows were infused with either 0.25 mL saline or 0.5 mg of PGF2α (in 0.25 mL saline) in the uterine horn
ipsilateral to the corpus luteum (CL)-bearing ovary. Luteal blood flow was assessed using trans-rectal power Doppler ultrasonography (Frequency 6 MHz, PFR 2000 Hz, and depth 60 mm) 15 mins prior to the first infusion (-15 mins), at time of the first
infusion (0 mins), every 15 mins for the following hour, and every hour thereafter (for 6 hrs). The percentage of luteal blood flow was later quantified using ImageJ software. CL were deemed functional if serum progesterone levels were >1 ng/mL or
regressed if < 1 ng/mL at time of ovariectomy (48 hrs following first infusion). All CM (A-D), FM (E-H), and CM versus FM interactions (I-K) between saline or PGF2α infused groups, and PGF2α-functional and non-functional CL groups. CM-Saline
(n=4); CM-PGF2α Regressed (n=6); CM-PGF2α Functional (n=4); FM-Saline (n=3); FM-PGF2α Regressed (n=4); FM-PGF2α Functional (n=9). *Significant differences between supplementation or infusion group within time of scan. Data are presented
as mean ± SEM. Note: overlapping error bars were removed for effective visualization purposes.
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Second Infusion
All CM associated groups can be visualized in figure 3.21A, and all FM associated
groups can be visualized in figure 3.21E. We found that blood flow did not significantly
differentiate (p<0.05) between CM-Saline (n=4) and CM-PGF2α Regressed (n=6; figure 3.21B)
groups, despite an apparent increase in the CM-PGF2α Regressed group. These results indicate
the second infusion of PGF2α did not influence blood flow as drastically in CM supplemented
cows with a regressing CL. Luteal blood flow in CM-PGF2α Functional cows (n=4) was
differentially influenced however, as blood flow was significantly elevated (p<0.05) 30 mins
post infusion compared to both CM-Saline (figure 3.21C) and CM-PGF2α Functional groups
(figure 3.21D). Interestingly, no FM supplemented groups significantly differed from the FMSaline control (n=3), however, both the FM-PGF2α Regressed (n=4; figure 3.21F) and the FMPGF2α Functional (n=9) had a lower starting blood flow, denoting the importance of assessing
the change in percent luteal blood flow. Furthermore, we found that supplementation group (CM
vs FM-Saline; figure 3.21I) did not differentially influence basal luteal blood flow. Why both
control groups underwent a reduction in blood flow from 3- to 6-hrs post infusion is unclear.
Similarly, when comparing the patterns in blood flow between CM- and FM-PGF2α Regressed
groups, no significant difference (p>0.05) was observed, showing that supplement group had no
effect on luteal blood flow in regressing CL, as was to be expected. Finally, following analysis of
CM and FM-PGF2α Functional groups, CM supplemented animals had an earlier, and more
robust increase in luteal blood flow, as evident by the significant increase in flow 30 mins post
infusion.
While supplementation does not appear to maintain luteal blood flow as we had
hypothesized, nor is luteal blood flow different in functional vs regressing CL, it would appear as
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if FM supplementation reduced the intensity of the luteal blood flow response within the first
hour following infusion.
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Figure 3.21
Fish Meal (FM) Supplemented Cows Had a Blunted Response in Luteal Blood (Percentage of Luteal Blood Flow) When Compared to Corn Gluten Meal (CM) Supplemented Cows Following the Second Low Dose Intra-Uterine Infusion of Prostaglandin
F2 Alpha (PGF2α)
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Note. Cows were supplemented with either CM or FM for 63 days, during which estrus was synchronized. On day 10-12 following onset of estrus, cows were infused with either 0.25mL saline or 0.5mg of PGF2α (in 0.25 mL saline) in the uterine horn
ipsilateral to the CL-bearing ovary. The first infusion occurred 12 hrs prior to the second infusion. Luteal blood flow was assessed using trans-rectal power Doppler ultrasonography (Frequency 6 MHz, PFR 2000 Hz, and depth 60 mm) 15 mins prior to
the second infusion (-15 mins), at time of the second infusion (0 mins), every 15 mins for the following hour, and every hour thereafter (for 6 hrs). Blood flow was also assessed directly prior to the time of ovariectomy (48 hrs following first infusion).
The percentage of luteal blood flow was later quantified using ImageJ software. CL were deemed functional if serum progesterone levels were >1 ng/mL or regressed if < 1 ng/mL at time of ovariectomy. All CM (A-D), FM (E-H), and CM versus FM
interactions (I-K) between saline or PGF2α infused groups, and PGF2α-functional and non-functional CL groups. CM-Saline (n=4); CM-PGF2α Regressed (n=6); CM-PGF2α Functional (n=4); FM-Saline (n=3); FM-PGF2α Regressed (n=4); FM-PGF2α
Functional (n=9). *Significant differences between supplementation or infusion group within time of scan. Data are presented as mean ± SEM. Note: overlapping error bars were removed for effective visualization purposes.
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First and Second Infusions
We found no significant differences (p>0.05) in luteal blood flow between the first and
second infusions, independent of supplementation or infusion group, indicating the sequence of
infusions did not differentially influence luteal blood flow (figure 3.22A-F). This was of
particular interest specifically with regards to the CM-PGF2α Regressed group, considering
blood flow was significantly elevated following the first infusion when compared to the control
(figure 3.20B), but not following the second (figure 3.21B). Similarly, with regards to FMPGF2α Functional cows, a significant difference in blood flow was observed in the first infusion
(figure 3.20G), but not the second (figure 3.21G). In fact, both CM and FM respective groups
closely matched each other in flow fluctuation trends between the first and second infusion. This
could be due to the variability in controls associated with a low sample size and early phase data
collection.
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Figure 3.22
Infusion Number (1st vs 2nd) of Prostaglandin F2 Alpha (PGF2α) Did Not Influence the Response in Luteal Blood Flow (Percentage of Luteal Blood Flow) in Corn Gluten Meal (CM) or Fish Meal (FM) Supplemented Cows
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Note. Cows were supplemented with either CM or FM for 63 days, during which estrus was synchronized. On day 10-12 following onset of estrus, cows were infused with either 0.25mL saline or 0.5mg of PGF2α (in 0.25 mL saline) in the uterine horn
ipsilateral to the corpus luteum (CL)-bearing ovary. The first infusion occurred 12 hrs prior to the second infusion, both infusions occurring at 0 mins. Luteal blood flow was assessed using trans-rectal power Doppler ultrasonography (Frequency 6 MHz,
PFR 2000 Hz, and depth 60 mm) Percentage of luteal blood flow was later quantified using ImageJ software. CL were deemed functional if serum progesterone levels were >1 ng/mL or regressed if < 1 ng/mL at time of ovariectomy. All CM (A-C) or FM
(D-F) interactions between saline or PGF2α infused groups, and PGF2α-functional and non-functional CL groups. CM-Saline (n=4); CM-PGF2α Regressed (n=6); CM-PGF2α Functional (n=4); FM-Saline (n=3); FM-PGF2α Regressed (n=4); FM-PGF2α
Functional (n=9). Data are presented as mean ± SEM. Note: overlapping error bars were removed for effective visualization purposes.
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Percent Difference of Luteal Blood
Flow Following Infusions
First Infusion
The percent difference in luteal blood flow was also quantified to assess relationships
with respect to the pre-infusion control (-15 mins of first infusion), however, variability within
controls was greatly increased as a result, and so potential relationships may be lost. All CM
interactions are summarized in figure 3.23A and all FM in figure 3.23E. By assessing percent
difference, the previously significant increase (p<0.05) in luteal blood flow between CM-Saline
and CM-PGF2α Regressed was lost, and no significant difference was detected (figure 3.23B).
However, the significant increase (p<0.05) between CM-Saline and CM-PGF2α Functional
groups was retained (figure 3.23C). Furthermore, the relationship between CM-PGF2α
Regressed and CM-PGF2α Functional groups was also maintained in that the CM-PGF2α
Functional group had an earlier, more robust increase in blood flow (p<0.05; figure 3.23D).
Interestingly, by comparing the percent differences in blood flow, CM-PGF2α Functional cows
had a significantly greater (p<0.05) blood flow 6 hrs post infusion, indicating prolonged blood
flow.
In assessing the data as percent difference, the variability and fluctuations occurring in
the FM-saline controls are made apparent, as means shift from ~0 to ~75% at the 2 hrs mark. The
lack of significant difference (p>0.05) between FM-Saline and FM-PGF2α Regressed groups
was replicated even after accounting for percent difference, as such the lack of a blood flow
response was made more apparent (figure 3.23F). The significant response in the FM-PGF2α
Functional group compared to the FM-Saline group, was however lost (p>0.05) despite a
promising spike 45 mins post infusion in the Functional group (Figure 3.23G). No differences
were detected between FM-PGF2α Regressed and FM-PGF2α groups (figure 3.23H), as would
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be expected considering a lack of independent effects relative to the control. When comparing
supplementation groups (figure 3.23I-K), only the PGF2α-Functional groups (figure 3.23K) had
significant differences in blood flow, as was observed prior to percent difference conversion. The
results demonstrate that conversion to percentage difference presents a more honest assessment
of the data and is more conservative with respect to generation of differential relations between
data as far as first infusion comparisons were concerned. Furthermore, other than the FM-PGF2α
Regressed group, all PGF2α infused groups underwent an increase in luteal blood flow within
the first 1 hr following exposure.
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Figure 3.23
Fish Meal (FM) Supplemented Cows Had a Blunted Response in Luteal Blood Flow (Percentage Difference of Luteal Blood Flow) When Compared to Corn Gluten Meal (CM) Supplemented Cows Following the First Low Dose Intra-Uterine Infusion of
Prostaglandin F2 Alpha (PGF2α)
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Note. Cows were supplemented with either CM or FM for 63 days, during which estrus was synchronized. On day 10-12 following onset of estrus, cows were infused with either 0.25mL saline or 0.5mg of PGF2α (in 0.25 mL saline) in the uterine horn
ipsilateral to the corpus luteum (CL)-bearing ovary. Luteal blood flow was assessed using trans-rectal power Doppler ultrasonography (Frequency 6 MHz, PFR 2000 Hz, and depth 60 mm) 15 mins prior to the first infusion (-15 mins), at time of the first
infusion (0 mins), every 15 mins for the following hour, and every hour thereafter (for 6 hrs). The percentage difference of luteal blood flow relative to the pre-infusions scan (-15 min) was later quantified using ImageJ software. CL were deemed
functional if serum progesterone levels were >1 ng/mL or regressed if < 1 ng/mL at time of ovariectomy (48 hrs following first infusion). All CM (A-D), FM (E-H), and CM versus FM interactions (I-K) between saline or PGF2α infused groups, and
PGF2α-functional and non-functional CL groups. CM-Saline (n=4); CM-PGF2α Regressed (n=6); CM-PGF2α Functional (n=4); FM-Saline (n=3); FM-PGF2α Regressed (n=4); FM-PGF2α Functional (n=9). *Significant differences between
supplementation or infusion group within time of scan. Data are presented as mean ± SEM. Note: overlapping error bars were removed for effective visualization purposes.
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Second Infusion
All CM interactions are summarized in figure 3.24A and all FM in figure 3.24E. When
assessing CM-Saline and CM-PGF2α Regressed groups, blood flow did not significantly differ
(p>0.05) at any time (figure 3.24B). However, CM-PGF2α Regressed cows underwent a clear
increase in blood flow up to 45 mins post infusion, and subsequently declined back to starting
concentrations. A similar trend was observed in the CM-Saline and CM-PGF2α Function
comparison (figure 3.24C). The insignificance may be due, in part, to the unexpected variability
within saline control cows. While both CM-PGF2α Regressed and CM-PGF2α Functional cows
followed a similar trend of increased percent blood flow following PGF2α exposure, Functional
cows had an earlier, more robust response (figure 3.24D), a comparative trend to the first
infusion (figure 3.23D). Across all FM-FM interactions, no significant differences (p>0.05) were
observed (Figure 3.24F-H). However, despite a lack of significance, blood flow values in PGF2α
infused groups (both FM Regressed and FM functional) followed a similar trend to that of CMPGF2α groups, wherein blood flow spiked within the first hour following infusion and returned
to base level within 6 hrs post infusion. When assessing relationships between CM and FM
groups, we observed once again that supplement did not significantly alter (p>0.05) base luteal
blood flow (figure 3.24I). Also, no significant differences (p>0.05) were detected between CMPGF2α Regressed and FM-PGF2α Regressed groups (figure 3.24J). While both CM-PGF2α
Functional and FM-PGF2α Functional groups underwent a similar spike in luteal blood flow
within the first 1 hr following infusion, the spike in CM cows pre-ceded those of FM
supplemented cows (p<0.05; figure 3.24K), although this did not appear to differentiate long
term luteal blood flow, as flow was comparable from 45 mins post infusion until time of
ovariectomy. Akin to findings in figure 20, no significant differences (p>0.05) were found by the
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48 hrs time point between any groups, indicating that blood flow was conserved independent of
the CL functional state. Moreover, while converting data to percent difference reduced the
number of significant relationships, a more consistent trend was observed in luteal blood flow
following exposure to PGF2α; luteal blood flow increases within 1 hr following exposure.
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Figure 3.24
Fish Meal (FM) Supplemented Cows Had a Blunted Response in Luteal Blood Flow (Percentage Difference of Luteal Blood Flow) When Compared to Corn Gluten Meal (CM) Supplemented Cows Following the Second Low Dose Intra-Uterine Infusion
of Prostaglandin F2 Alpha (PGF2α)
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Note. Cows were supplemented with either CM or FM for 63 days, during which estrus was synchronized. On day 10-12 following onset of estrus, cows were infused with either 0.25mL saline or 0.5mg of PGF2α (in 0.25 mL saline) in the uterine horn
ipsilateral to the corpus luteum (CL)-bearing ovary. The first infusion occurred 12 hrs prior to the second infusion. Luteal blood flow was assessed using trans-rectal power Doppler ultrasonography (Frequency 6 MHz, PFR 2000 Hz, and depth 60 mm) 15
mins prior to the second infusion (-15 mins), at time of the second infusion (0 mins), every 15 mins for the following hour, and every hour thereafter (for 6 hrs). Blood flow was also assessed directly prior to the time of ovariectomy (48 hrs following first
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infusion). Percentage difference of luteal blood flow relative to the pre-infusions scan (-15 min of first infusion) was later quantified using ImageJ software. CL were deemed functional if serum progesterone levels were >1 ng/mL or regressed if < 1
ng/mL at time of ovariectomy. All CM (A-D), FM (E-H), and CM versus FM interactions (I-K) between saline or PGF2α infused groups, and PGF2α-functional and non-functional CL groups. CM-Saline (n=4); CM-PGF2α Regressed (n=6); CM-PGF2α
Functional (n=4); FM-Saline (n=3); FM-PGF2α Regressed (n=4); FM-PGF2α Functional (n=9). *Significant differences between supplementation or infusion group within time of scan. Data are presented as mean ± SEM. Note: overlapping error bars
were removed for effective visualization purposes.
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First and Second Infusions
Comparable to results from the raw luteal blood flow (figure 3.22), data converted to
percentage difference of luteal blood flow (all time points relative to the first scan prior to any
infusions; -15 min of first infusion) yielded no significant differences (p>0.05) between the first
or second infusion of PGF2α (figure 3.25). These results indicate that the succession of PGF2α
infusions did not influence percentage difference of luteal blood flow. Furthermore, transforming
data to percentage difference generated no new information with respect to relationships between
infusions.
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Figure 3.25
Infusion Number (1st vs 2nd) of Prostaglandin F2 Alpha (PGF2α) Did Not Influence the Response in Luteal Blood Flow (Percentage Difference of Luteal Blood Flow) in Corn Gluten Meal (CM) or Fish Meal (FM) Supplemented Cows
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Note. Cows were supplemented with either CM or FM for 63 days, during which estrus was synchronized. On day 10-12 following onset of estrus, cows were infused with either 0.25mL saline or 0.5mg of PGF2α (in 0.25 mL saline) in the uterine horn
ipsilateral to the CL-bearing ovary. The first infusion occurred 12 hrs prior to the second infusion, both infusions occurring at 0 mins. Luteal blood flow was assessed using trans-rectal power Doppler ultrasonography (Frequency 6 MHz, PFR 2000 Hz,
and depth 60 mm) Percentage difference of luteal blood flow relative to the pre-infusions scan (-15 min of first infusion) was later quantified using ImageJ software. CL were deemed functional if serum progesterone levels were >1 ng/mL or regressed if
< 1 ng/mL at time of ovariectomy. All CM (A-C) or FM (D-F) interactions between saline or PGF2α infused groups, and PGF2α-functional and non-functional CL groups. CM-Saline (n=4); CM-PGF2α Regressed (n=6); CM-PGF2α Functional (n=4);
FM-Saline (n=3); FM-PGF2α Regressed (n=4); FM-PGF2α Functional (n=9). Data are presented as mean ± SEM. Note: overlapping error bars were removed for effective visualization purposes.
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Luteal Mass at Time of
Ovariectomy
Mass of the CL at time of ovariectomy was assesed to determine the influence of CM or
FM supplementation on luteal involution following PGF2𝛼 exposure. Here, reported masses
were from 48 hrs ovariectomies only. Luteal mass was not influenced by PGF2α infusions in the
CM-PGF2𝛼 Functional group (n=3), as the mass did not signficantly differ (p>0.05) from CMSaline controls (n=4) but did (p<0.05) from the CM-PGF2𝛼 Regressed group (n=6; figure
3.26A). Luteal mass was, however, influenced by PGF2𝛼 infusions in the FM-PGF2𝛼 Functional
group (n=8), as CL mass signficiantly differed (p<0.05) from the FM-Saline control (n=4) but
not (p>0.05) the FM-PGF2𝛼 Regressed group (n=4; figure 3.26B). The influence of CM
supplementation on luteal mass following PGF2α exposure is furtherd by a trending increase
(p<0.1) in mass in the CM- vs FM-PGF2𝛼 Functional group (figure 3.26E). Neither
supplementaiton group (CM or FM) influenced basal mass of the CL (p>0.05; figure 3.26C), nor
the mass of the regressed CL (p>0.05; figure 3.26D).
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Figure 3.26
Structural Regression Occurred in Both Corn Gluten Meal (CM) and Fish Meal (FM) Supplemented Cows Following Two Low Dose Intra-Uterine Infusion of Prostaglandin F2 Alpha (PGF2α)
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Note. Cows were supplemented with either CM or FM for 63 days, during which estrus was synchronized. On day 10-12 following onset of estrus, cows were infused with either 0.25 mL saline or 0.5 mg of PGF2α (in 0.25 mL saline) in the uterine horn
ipsilateral to the corpus luteum (CL)-bearing ovary. The cows were infused twice, each infusion 12 hrs apart. 48 hrs following the first infusion, CL were removed via trans-rectal ovariectomy. CL were dissected from the ovary and massed (g). Any CL
containing a fluid filled cavity were massed following removal of fluid. CL were deemed functional if serum progesterone levels were >1 ng/mL or regressed if < 1 ng/mL at time of ovariectomy. All CM (A), FM (B), and CM versus FM interactions (CE) between saline or PGF2α infused groups, and PGF2α-functional and non-functional CL groups. CM-Saline (n=4); CM-PGF2α Regressed (n=6); CM-PGF2α Functional (n=3); FM-Saline (n=4); FM-PGF2α Regressed (n=4); FM-PGF2α Functional
(n=8). *Significant difference (p<0.05) between treatments. p values were reported if p<0.1, indicating statistical trend. Data are presented as mean  SEM.
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CHAPTER IV
DISCUSSION
Cytokine Exposure and Omega-3 Fatty Acid Pre-Treatment
Middle Stage Corpora Lutea are
Less Sensitive to Cytokines
We first sought to explore if the cytotoxic effects of tumor necrosis factor alpha (TNFα)
and interferon gamma (IFNγ) on bovine luteal cells was dependent on the luteal stage from
which cells were derived. From our results, we found a reduced, though marginal, reduction in
sensitivity to TNFα and IFNγ by cells from middle staged CL when compared to those of early
or late staged CL. The difference in viability between the mixed luteal cell population isolated
form middle and early or late staged CL may be because each luteal stage presents a unique
microenvironment with differing external stimuli, and as such, may pre-dispose cells to
differential transcriptional regulation and subsequent differing responses to stimuli. For example,
cells in the early CL undergo extensive programmed cell death during development of the tissue,
have an abundance of neutrophils and macrophages, and luteal cells express MHC II. The
abundance of M2 and N2 macrophages and neutrophils, respectively, would insinuate that while
an inflammatory process, the early CL may be more regulatory and akin to a wound healing
environment (Jiemtaweeboon et al., 2011; Penny et al., 1999; Petroff et al., 1999; Reibiger &
Spanel-Borowski, 2000; Sakumoto et al., 2000; Terranova & Rice, 1997). However, the unique
environment may condition cells to be more receptive to cell death stimuli. Late-stage CL begin
to transition towards a pro-cell death and inflammatory environment (regardless of the presence
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of prostaglandin F2 alpha [PGF2α]) as evident by increased expression of the pro-inflammatory
TNFα and expression of MHC II, the latter of which is supressed only by pregnancy (Benyo et
al., 1991; Miyamoto et al., 2005; Pate, 1995; Penny et al., 1999). Finally, middle stage CL
generally represent a regulatory environment focused on stabilization and establishment of
progesterone output, as evident by a significant presence of gamma delta regulatory T cells and
interlukin-10 expression (Shirasuna & Miyamoto, 2016; Walusimbi & Pate, 2014).
Moreover, it is plausible that the difference in cellular viability between stages is related
to the expression of the pro-death TNFRI. Interestingly, we found that following TNFα and IFNγ
exposure, cells from a middle stage CL had a near significant reduction in TNFR1 steady state
mRNA expression when compared to the late staged CL. Since cellular exposure to TNFα and
IFNγ synergistically increases gene expression for the TNFR1 receptor (Hojo et al., 2010;
Tsujimoto et al., 1986), a reduced capacity for the cytokines to increase expression of TNFRI
may protect cells from unwarranted cellular death to optimize luteal function. However, why
early-stage CL were significantly more sensitive to TNFα and IFNγ, despite insignificant
differences in TNFR1 expression, remains unclear and assessment of protein expression is
necessary to further understand the relationship between TNFRI abundance and TNFα and IFNγ
sensitivity. It is also plausible that the differential expression of TNFR1 could be due to the
differential abundance of cell types. While the ratio of 3𝛽-HSD positive cells (presumably
steroidogenic cells) was relatively consistent across stages in our co-cultures, endothelial and
fibroblast cells may not have been equally represented due to differential ratios across the luteal
cycle (Lei et al., 1991).
Additionally, since cellular viability was different between CL staged groups, we
explored potential differences in biomarkers for programmed cell death (apoptosis and
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necroptosis). Interestingly, we found that MLKL gene expression following TNFα and IFNγ was
elevated in late luteal stages when compared to early staged CL. Necroptosis is a more
aggressive form of cellular death, wherein cells are lysed open and contents expelled (Newton &
Manning, 2016; Pasparakis & Vandenabeele, 2015). As such, necroptosis may stimulate a larger
inflammatory response when compared to the more controlled apoptosis. A CL transitioning to
regression may be more inclined to undergo cellular death by way of necroptosis, as it may
expedite the establishment of the pro-inflammatory environment contributing to regression. It is
also plausible that the middle stage resistance to cell death is accomplished through
posttranslational regulation of apoptotic and necroptotic biomarkers (Murphy & Vince., 2015;
Zamaraev et al., 2017), and as such, further experimentation is required. Regardless, our findings
consistent with previous works, wherein TNFα and IFNγ increased biomarker expression of both
apoptotic and necroptotic programmed cell death signaling pathways (Hojo et al., 2016, 2019).
These findings potentiate the notion that the cytokines TNFα and IFNγ induce differing degrees
and mechanisms of action of cellular death in bovine luteal cells depending on the luteal stage.
Omega-3 Fatty Acid PreTreatment Does Not
Reduce Cytokine
Cytotoxicity
It has been demonstrated on multiple accounts that in cellular culture, TNFα and IFNγ reduce
cellular viability by way of reactive oxygen species (ROS) production, as treatment with reactive oxygen
scavenger molecules such as glutathione and SOD reduced a complete or partial proportion of the
cytokine-induced cellular death (Petroff et al., 2001; Pru et al., 2003). Omega-3 fatty acids
eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA) have been shown to reduce ROS activity
(Garrel et al., 2012; Giordano & Visioli, 2014; Jones et al., 2013). However, in this study, EPA and DHA
pre-treatment did not influence (positively or negatively) the cytotoxicity of TNFα and IFNγ.
Unsurprisingly, apoptotic gene expression at any luteal stage of culture was not influenced by omega-3
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fatty acid pre-treatment, however, necroptotic signaling (MLKL gene expression, but not RIPK1 or
RIPK3) was significantly reduced following pre-treatment in early staged cultures exposed to TNFα and
IFNγ. Furthermore, in middle staged cultures, EPA and DHA pre-treatment reduced the basal levels of
MLKL expression, but not following cytokine exposure. While EPA and DHA pre-treatment did not
influence the degree of cell viability, the omega-3 fatty acids may none the less regulate the type of
cellular death (apoptotic vs necroptotic) in early luteal staged cultures exposed to TNFα and IFNγ.
Similar anti-necroptotic effects of EPA and DHA have been observed in the porcine intestine (Xiao et al.,
2020), though potential mechanisms by which the omega-3 fatty acids are influencing necroptosis have
scarcely been explored in the literature. Independent of luteal stage, these findings support the

rejection of our initial hypothesis, as EPA and DHA did not differentially influence cellular
viability following exposure to TNFα and IFNɣ, nor did it influence apoptotic gene expression.
However, EPA and DHA did appear to reduce TNFα and IFNɣ induced necroptotic gene
expression.
Moreover, it is plausible that while omega-3 fatty acids are not reducing the cytotoxic
effects of TNFα and IFNɣ in vitro, omega-3 fatty acids may be reducing the release of TNFα and
IFNɣ following PGF2𝛼 exposure in vivo, there in reducing the amount of cell death and
preserving luteal function. In fact, in a review by McDaniel et al. (2008), omega-3 fatty acids
reduce basal levels of pro-inflammatory cytokines, suggesting a potential influential role in proinflammatory cytokine management in the CL.
Cytokines Induced Expression of
Pro-Inflammatory Pathways
We demonstrated that TNFα expression, independent of luteal stage, is elevated
following TNFα and IFNγ exposure, indicating intracellular readiness for a feed forward loop.
The notion of a feed forward loop is of relevance when considering the event of luteal
regression, wherein a positive feedback loop accelerating cell death and local inflammation may
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expedite luteal regression and thus reduce the time for a subsequent estrous cycle (chance at
fertilization).
Additionally, we demonstrated that following cytokine exposure, NF𝜅B gene expression
was also elevated. NF𝜅B regulates an array of cellular processes, including regulation of
immunoregulatory proteins, cytokines (such as TNFα), growth factors, and cell survival
(Oeckinghaus & Ghosh, 2009). The activation of NF𝜅B by way of TNFα is a well-supported
mechanism and may be an additional source of immunological regulation and propagation by
luteal cells during luteal regression. In fact, a study demonstrated that TNFα and IFNγ
synergistically reduced protein abundance of the NFκB inhibitor, nuclear factor of kappa light
polypeptide gene enhancer in B-cells inhibitor, alpha (IκBα), in bovine luteal cell cultures (Suter
et al., 2001), indicating subsequent activation of the NF𝜅B transcription factor. It is also
plausible that elevated expression of NF𝜅B —when assuming equal translation of protein
expression and activity—further propagates synthesis of TNFα therein contributing to further
cellular death during luteal regression; all of which requiring further experimentation to
conclude. As such, how the changes in gene expression that we observed translate to abundance
and activity of NFκB protein must be further explored.
While we found no effects of EPA and DHA pre-treatment on the modulation of TNFR1,
TNFα or NF𝜅B expression, it remains plausible that because we did not replicate the complexity
of tissue in a two-dimensional environment, nor did we accommodate interactions between
immune cells, steroidogenic cells and endothelial cell, physiological effects may have been
missed.
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Cytokines Regulate Steroidogenic
Gene Expression
In a purified small and large steroidogenic cell culture, PGF2α does not simply or directly
reduce steroidogenic capacity or cellular viability (Alila et al., 1988; Pate, 1996; Pate & Condon,
1989). Instead, it has been demonstrated that the environment of the culture, including the
concoction of molecules and cellular interactions (i.e., co-cultures), determines the effects of
PGF2α (Korzekwa et al., 2008). In fact, Pate and Keyes (2001) considered the potential role that
immune cells and their secretions play during luteal regression and inhibition of steroidogenesis,
a theory that has, and continues to be supported by the evidence that pro-inflammatory cytokines
such as TNFα and IFNγ are 1) present during luteal regression (Kliem et al., 2009; Petroff et al.,
1999) 2) are cytotoxic to isolated bovine luteal endothelial cells and isolated luteal steroidogenic
cells (Hojo et al., 2016) 3) reduce LH-stimulated progesterone output (Benyo & Pate, 1992;
Fairchild & Pate, 1991) and 4) in vivo studies have demonstrated that exposure to low doses of
TNFα reduces progesterone output comparable to PGF2α exposure (Korzekwa et al., 2008;
Skarzynski et al., 2003a). Here, we furthered this theory by demonstrating that TNFα and IFNγ
reduced abundance of steroidogenic genes STARD1 and CYP11A1. However, it is unclear
whether the reduction in steroidogenic gene expression is a result of transcriptional repression or
programmed cell death in steroidogenic populations, therefore the subject requires further
experimentation to clarify. Of note, CYP11A1 gene expression appeared to be insignificantly
influenced by the cytokine exposure in early staged cultures, though staged cultures that
underwent a significant reduction in CYP11A1 (i.e., middle, and late) had a comparably low
abundance of gene expression to that of the early staged cultures following cytokine exposure. In
relation to our findings, studies have demonstrated that ceramide, which is elevated following
TNFRI activation in bovine luteal derived endothelial cells (Pru et al., 2003), reduces activity of
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a steroidogenic enzymes (CYP19A1) in non-luteinized granulosa cells (Santana et al., 1995)—
but whether ceramide has similar effects on progesterone synthesizing enzymes in luteinized
cells has yet to be gleaned.
Taken together, the inhibitory influence of TNFα and IFNγ on steroidogenic gene
expression occurred independent of luteal stage, indicating that steroidogenic luteal cells may be
susceptible to the cytotoxic or inhibitory effects of TNFα and IFNγ at all luteal stages. However,
evidence by some research groups demonstrates that certain endothelial and fibroblast cells
express STARD1, and cells of the skin express the CYP11A1 gene (Razin et al., 2021; Slominski
et al., 2004). As such, it is plausible that cytokine-induced cell death in the endothelial and
fibroblast cells in our co-cultures may be responsible for the decline in steroidogenic gene
expression. Therefore, it is imperative we further elucidate if the decline in steroidogenic gene
expression is occurring in large and small luteal cells. Regardless of the cell types targeted,
results here support the notion that TNFα and IFNγ are one of many players aiding in the demise
of the corpus luteum.
Fish Meal Supplementation on Luteal Blood Flow
A Pulse in the Percentage of Luteal
Blood Flow During Regression
The CL is an extremely vascularized gland, a necessity for the adequate delivery of
cholesterol and nutrients to sustain the high demands of steroidogenesis. As such, ameliorating
our understanding of luteal blood flow throughout the estrous cycle is imperative and may
provide key insight into prolonging the lifespan of the gland, as reduced CL vascularization is an
indicator of late luteal regression. It has been demonstrated on multiple accounts that 30 mins,
and up until 2 hrs following exposure to PGF2α, luteal blood flow increases (Acosta et al., 2002;
Ginther et al., 2007), a result we repeated here as all PGF2α infused groups had an increase in
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the percentage difference in luteal blood flow. It is important to note that, in our results, not all
groups exposed to PGF2α underwent a significant increase in blood such that it differed from
saline controls. However, all PGF2α -infused groups did undergo an apparent increase within 1
hr following infusion time— made apparent when assessing percent difference (percent change)
in luteal blood flow. The lack of statistical significance between PGF2α and saline infused
groups may well be due to the variation in our control cows associated with a small sample size,
as we expected blood flow to be unchanged following saline infusions, as per findings in the
literature (Ginther et al., 2007). It is therefore imperative we augment numbers to distinguish
between biology and inter-animal variation.
It is also plausible that our use of power Doppler ultrasonography (with an upper blood
flow detection limit of 0.3 cm/s) compared to Acosta et al. (2002) and Ginther et al.’s (2007) use
of color Doppler ultrasonography (lower detection limit of 6-10 cm/s) undervalued the true spike
in percent of luteal blood flow that occurs because of our inability to detect and transmit signal
for faster moving blood. Regardless, an irrefutable increase in the percent of luteal blood flow
occurs following PGF2α exposure. A frequently hypothesized mechanism by which luteal blood
flow increases is by way of nitric oxide (NO) release in response to PGF2α, as NO is a potent
vasodilator present following PGF2α administration and following the onset of natural luteolysis
(Shirasuna et al., 2004). A study by Shirasuna et al., (2008) demonstrated that administration of a
nitric oxide analogue replicated the spike in luteal blood flow 2 hrs following exposure.
Furthermore, a research group showed that inhibition of nitric oxide synthase (NOS) reduced
PGF2α-induced luteal regression (both structural and functional), indicating it is an imperative
molecule downstream of the initial PGF2α pulses (Jaroszewski & Hansel, 2000). While NO
clearly follows PGF2𝛼 exposure, how PGF2α induces activation of NOS and subsequent NO
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release has yet to be demonstrated in the cow CL. A plausible mechanism includes PGF2α
binding to the G-protein coupled PGF2α receptor (FP) and activating NOS activity; PGF2α
binding to the FP on luteal endothelial cells of smooth muscle-encircled arterioles (Lee et al.,
2009; Shirasuna et al., 2008) could transduce activation of NOS via Ca2+ influx and
phosphorylation events which would increase NO synthesis (Rafikov et al., 2011; Skarzynski et
al., 2000). The elevated synthesis of NO would lead to vasodilation in the adjacent smooth
muscle cells of arterioles, and the hallmark surge in blood flow would occur. In support of this
theory, both endothelial NOS (eNOS) and inducible NOS (iNOS) protein and mRNA expression
are elevated in the late corpus luteum, which may be in preparation for the onset of luteal
regression allowing for a rapid, but non-immediate increase in luteal blood flow (Miyamoto et
al., 2005; Skarzynski et al., 2003b). Shirasuna et al., (2008) also demonstrated that expression of
eNOS was specific to the luteal periphery, and FPs were more abundant on peripheral luteal cells
proximal to larger smooth muscle arterioles, therein supporting the notion that PGF2𝛼 would be
primarily activating endothelial cell NOS. An additional mechanism potentially denoting the
changes in blood flow during luteal regression includes an ischemia reperfusion model. Ischemia
occurs when occlusion of blood vessels—most commonly due to a physical blockade such as
atherosclerosis, thromboses, embolism, or torsion—interfere with normal flow. As a result,
oxygen distribution to cells is diminished such that metabolic processes slow, ROS accumulate,
and intracellular damage occurs (Collard & Gelman, 2001; Kalogeris et al., 2012). While
prolonged ischemia can cause extensive damage to tissue, a rapid, reintroduction of blood
(reperfusion) to provide oxygen to the deprived cells can expedite, if not worsen, the damage
done to cells (Collard & Gelman, 2001). The flux in blood flow that we see following PGF2α
exposure may in fact be a reperfusion event following moderate ischemia, as we observed
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similar increases in luteal blood flow as other induced ischemia-reperfusion models (Miao et al.,
2015). We propose moderate, rather than severe ischemia, as we detect no decrease in luteal
blood flow 15 mins following either infusion. It is possible that arteriolar occlusion occurs
shortly after PGF2α administration, due to the vasoconstrictive potential of the prostaglandin, but
has been missed as a single group has yet to document real time changes in luteal blood flow
between 0- and 15-mins post PGF2α administration. Classical signs of ischemia include
production of ROS, elevation in cytokine and chemokines, increased neutrophil recruitment and
diapedesis, and endothelial cell dysfunction; all of which occur at differential time points in the
CL following PGF2α exposure (Dorweiler et al., 2007; Kalogeris et al., 2012; Kato et al., 1997;
Sawyer et al., 1990; Shirasuna et al., 2012;). A brief reduction in metabolic demands due to the
hypoxic environment would diminish production of progesterone in the CL (Nishimura et al.,
2008), and as such, an ischemic event may be responsible for the functional regression preceding
that of structural regression. An ischemic event may also explain why we see a brief rebound in
serum progesterone around time of recovery in blood flow.
Understanding the true cause and effect of the spike in percentage of luteal blood flow
during luteal regression is essential, as to truly generate strategies for interventions in luteal
regression, we must uncover the physiological processes at play. Moreover, understanding the
physiology regulating blood flow during luteal regression augments possibilities for using the CL
as a model system for understanding vascular physiology and pathology interventions.
Luteal Blood Flow is Maintained Forty-Eight
Hours Following Infusions Regardless of
Luteal Functional State
Following the spike in luteal blood flow, it has been reported that a steady decline occurs
until 48 hrs post PGF2α exposure, wherein flow is significantly reduced compared to pre-
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exposure ultrasound scans (Acosta et al., 2002; Ginther et al., 2007). However, these results were
not repeated in our study. Instead, we found that following the spike in percent of luteal blood
flow 30 mins to 1 hr following the first infusion of PGF2α, blood flow recovered and matched
that of the control within 4 hrs following time of infusion and did not significantly differ
thereafter. One potential reason for our differing results may be due to the differential power in
detection of slower moving blood. As previously mentioned, both Acosta et al. (2002) and
Ginther et al. (2007) used color Doppler when gathering data, and as such were limited to
assessing flows faster than 6-10 cm/s. The apparent reduction in blood flow may therefore be due
to an inability to detect and transmit the signal from slower flowing blood that is in fact
maintained. In using power Doppler, we were able to detect and transmit signals from blood flow
ranging 0-0.3 cm/s and demonstrated that while blood flow did drop back to a basal level, it did
not significantly differ from pre-PGF2α exposure scans. Thus, it is worth considering that
following PGF2α exposure, whole blood flow does slow, it may not be to the degree implied by
Acosta et al. (2002) and Ginther et al. (2007). Also, a group tracking luteal blood flow following
onset of natural luteolysis found that blood flow underwent a much slower decline, to such a
degree that the percentage of luteal blood flow did not significantly differ from pre-infusion
values 48 hrs following pulsatile secretions of PGF2α (Shirasuna et al., 2008). In naturally
occurring luteolysis, luteal derived vasoconstrictive factors ET-1, ANG II, and PGF2α reach
uppermost means 3 days following onset of luteolysis. If we then compare trends for luteal blood
flow and expression of vasoconstrictive factors, the reduction in luteal blood flow (below the
original flow threshold) occurs roughly 2-3 days following onset (Miyamoto et al., 2005;
Shirasuna et al., 2004, 2008). Maintenance of some degree of blood supply throughout the tissue
would be of particular importance to sustain the metabolic demands and metabolite clearance
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required for tissue remodeling and glandular involution (Pober & Sessa, 2015). In fact, following
a luteolytic dose of PGF2α, the population of endothelial cells does not significantly differ 12 hrs
post exposure nor in naturally regressing CL (Hojo et al., 2009). Additionally, smooth muscle
encapsulated arteriole density increases during both natural and induced luteal regression (Hojo
et al., 2009), and smooth muscle cell actin is maintained (Vonnahme et al., 2006). Therefore,
evidence would suggest the vasculature supplying the gland does not recede directly following
exposure, and in fact is maintained relative to other cells, if not at a greater proportion when
considering smooth muscle arterioles. Visualization and quantification of the vasculature in our
collected tissue at time of ovariectomy may elucidate why we see no reduction in luteal blood
flow. Additionally, the speed by which luteal blood flow recovered in our study follows the
temporal secretion pattern of vasoconstrictive factors in a naturally regressing CL, indicating our
results may be representative of a more physiological response; 2 hrs following the start of
natural luteolysis, luteal secretions of ET-1, ANG II, and PGF2α (potent vasoconstrictors) all
significantly rise (Shirasuna et al., 2004). Miyamoto et al. proposed that the ET-1 and ANGII are
released because of the shear stress from the acute spike in luteal blood flow to reestablish flow
to homeostatic levels (2005). While vasculature to the gland does eventually dwindle days
following PGF2α exposure (exogenous or endogenous), the timing of the decline requires further
elucidation, as differing results were found here with use of a more sensitive ultrasound
technique.
Moreover, it is also important to consider we may be missing potential differences in the
percentage of luteal blood between supplementation groups as all data collection stopped 48 hrs
following the first infusion, and so key differences may be occurring past our window of
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analysis. We therefore may miss an effect such as maintenance of the percentage of luteal blood
flow that could explain the luteoprotective effects of FM supplementation.
These preliminary findings do not support the initial hypothesis that luteal blood flow is
prolonged in CL that did not regress 48 hrs following PGF2α exposure, however, a more
extensive sample size is required to truly reject the hypotheses.
Fish Meal Supplementation Creates the Optimal Response
in Luteal Blood Flow Following Infusions
As previously discussed, NO plays a critical role in luteal regression. As suggested by
Shirasuna et al. (2004), the increase in luteal blood flow stimulated in part by the vasodilator NO
may be a crucial step in the instigation of luteal regression. In fact, despite prevalence of PGF2α
receptors on cells of the early CL, prior to day 4 of the estrous cycle, luteal exposure to PGF2α
has no effect on luteal regression nor on luteal blood flow (Acosta et al., 2002; Tsai et al., 1996).
Likewise, administration of an NO analogue does not elicit the increased percentage of luteal
blood flow observed in the middle-staged CL, and protein expression for eNOS was significantly
decreased in the early-stage CL relative to the middle and late luteal stages (Skarzynski et al.,
2003b). The culmination of reported findings insinuates that the changes in luteal blood flow
play a crucial role in luteal regression, and as such, it is plausible that a reduced response in
luteal blood flow following PGF2α may prolong the lifespan of the gland. Interestingly, we
observed changes in responsiveness between CM and FM supplemented groups, wherein FM
supplemented cows comparatively had a less robust and shorter duration of elevated percent
luteal blood flow following PGF2α exposure. This was denoted by a quicker recovery time of 1
hr following the first PGF2α exposure in FM supplemented cows, versus a lack of complete
recovery 6 hrs post infusion (percent luteal blood flow did not return to starting blood flow
values) in the CM supplemented cows. While the differences between supplementation groups
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were less pronounced following the second dose, a similar trend was none-the less observed.
Since FM supplementation led to a 114.4% increase in the rate of functional CL following
PGF2α infusions when compared to CM supplemented cows (a near significant difference), a
blunted increase in luteal blood flow following PGF2α administration may favor CL
functionality. However, we would then expect regressing CL to have a significantly pronounced
response to luteal blood flow, yet this is not the case for FM-PGF2α Regressed CL. From our
results, it is plausible that components of FM supplementation (presumably the omega-3 fatty
acids) may dampen the flux in blood flow following PGF2α exposure, such that only minor
structural and regressive trends occur that none the less allow for maintenance of a functional
gland, as was evident by reduced CL mass and a slight decline in, but ultimate maintenance of,
serum progesterone above 1 ng/mL at time of ovariectomy in PGF2α-Functional glands. In other
words, the degree of the response in blood flow dictates the fate of the gland. Earlier, we
proposed that an ischemia-reperfusion event may occur during luteal regression. In fact, differing
lengths of ischemia, as well as the tissue response following reperfusion greatly impacts the
outcome of a tissue (Kalogeris et al., 2012). Omega-3 fatty acids have been shown to reduce
cellular injury caused by reperfusion injuries (Jing et al., 2014; Kim et al., 2013; Qi et al., 2017),
and so it remains plausible that FM supplementation reduces the degree of reperfusion and as
such, more effectively prolongs glandular viability. It is also plausible that omega-3 fatty acids
reduced cellular damage following a reperfusion event, and to confirm such, assessment of
cellular stress biomarkers and programmed cell death between supplementation functional
groups is required. While FM supplementation does not appear to maintain luteal blood flow, it
does appear to alter the luteal flow response, which requires further exploration.
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Progesterone Decline During Luteal Regression
is Not Linearly Associated with Luteal Blood
Flow
In our current study, we found no correlation (data not shown) between serum
progesterone or luteal blood flow between any group 48 hrs following infusion, despite serum
progesterone being significantly different between groups. These findings are consistent with
those of Kaya et al. (2017) and Lüttgenau et al. (2011), who found that cows with differential
luteal blood flow had no statistical difference in progesterone output. However, other groups
found contradictory results, wherein blood flow was correlated with serum progesterone
(Miyazaki et al., 1998). Interestingly, the reduction in progesterone output during luteal
regression far precedes the eventual decrease in luteal blood flow, and as such, provides evidence
that blood flow may not be initially correlated with the progesterone decline soon after PGF2α
exposure. However, as previously discussed, it is plausible that early reduction in progesterone
synthesis may be because of moderate ischemia occurring following exposure to PGF2α.
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CHAPTER V
CONCLUSION
Early pregnancy loss continues to be a problematic in the cattle industry. Fish meal
dietary supplementation has demonstrated potential in improving overall pregnancy rates.
Moreover, fish meal supplementation reduces rates of luteal regression following low dose
infusions of PGF2α, and as such, may reduce rates of pregnancy loss on days 16-32 of gestation
in cattle. Prior to running large scale breeding trials, understanding the mechanisms by which
fish meal supplementation is luteoprotective will bolster our understanding of luteal regression,
as well as the role of omega-3 fatty acids in reproductive health and management. Here, we
hypothesized two mechanisms by which fish meal supplementation may reduce rates of luteal
regression. In the first mechanism, we postulated that EPA and DHA would reduce the cytotoxic
effects of two cytokines prevalent during luteal regression (TNFα and IFNγ) in bovine luteal cell
culture, as reduced cell death during luteal regression would, in theory, prolong glandular
function. The second mechanism we postulated suggested that fish meal supplementation would
retain the percentage of luteal blood flow to the corpus luteum in cows that did not regress 48 hrs
following exposure to low doses of PGF2α. Loss in luteal blood flow is hallmark of luteal
regression, and as such, maintenance of flow may prolong glandular function.
Cytokines and Omega-3 Fatty Acids
Findings here suggest that the cytokines TNFα and IFNγ have differing mechanisms of
action on cellular death in bovine luteal cells depending on the luteal stage. EPA and DHA pre-
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treatment did not influence the degree of cytotoxicity invoked by cytokines TNFα and IFNγ,
therein refuting our initial hypotheses and mechanism postulated. However, EPA and DHA pretreatment did reduce expression of the necroptotic biomarker MLKL either following TNFα and
IFNγ exposure in the case of early staged CL or reduced basal MLKL expression in the case of
middle staged CL. Taken together, EPA and DHA may have a potential regulatory role of the
mode of cellular death in bovine luteal cells. We also found that both TNFα and NF𝜅B gene
expression were elevated following exposure to TNFα and IFNγ, which is the first study to our
knowledge demonstrating the cytokine specific activation of genes involved in a proinflammatory feed forward loop in bovine luteal cells. Additionally, we contribute to the notion
that cytokines TNFα and IFNγ contribute to luteal regression by way of reducing steroidogenic
gene expression; whether this is in relation to functional or structural regression, however,
requires further exploration.
Findings here collectively contribute to our understanding of EPA and DHA and their
role in disrupting translational regulation of necroptotic signaling, as well as the transcriptional
influence of the pro-inflammatory molecules TNFα and IFNγ on pro-inflammatory markers in
bovine luteal cells.
Fish Meal Supplementation and Luteal Blood Flow
In this study, we replicated findings in the literature wherein the percentage of luteal
blood flow drastically increases following PGF2α administration in mid-cycle CL. However,
contrary to other groups, we demonstrated no change in the percentage difference in luteal blood
flow 48 hrs following PGF2α exposure. Instead, all PGF2α groups (independent of
supplementation) recovered back to pre-infusion blood flow values despite evidence of structural
and functional regression. We contribute these differences in findings to the type of Doppler

135
ultrasonography used, as we were able to detect slower moving blood, and so were able to
document sustained acute flow. Moreover, we compared the spike in percentage of luteal blood
flow following PGF2α administration to an ischemic-reperfusion event, as a portion of the blood
flow pattern and the entirety of cellular characteristics during luteal regression coincide with
reported features of ischemia and reperfusion related damage. Induction of ischemia reperfusion
would provide an effective mechanism for enhancement of luteal regression. Markedly,
extensive research is required to elucidate the entirety of physiological events culminating to
luteal regression, specifically with regards to the blood flow response. Our findings also
demonstrate that FM supplementation may be altering the degree of the blood flow reperfusion
in such a capacity that tissue health and maintenance is favored, as demonstrated by a greater
percent of functional CL in FM supplemented cows compared to CM supplemented cows
following two intrauterine PGF2α infusions, and a blunted increase in luteal blood flow.
However, a larger sample size is required to clarify the degree of error in saline infused cows.
Additionally, we demonstrated that serum progesterone declined independent of luteal blood
flow 48 hrs following infusion, though the relationship between blood flow and progesterone
may not be so simplistic as a linear relationship. While findings here do not support our initial
hypothesis that blood flow would be maintained in FM supplemented cows 48 hrs following low
dose, intra-uterine infusion of PGF2α, FM supplementation does appear to be altering luteal
blood flow; the implications of which require further exploration.
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Future Directions
Omega-3 Fatty Acids in the
Inhibitory Regulation of
Necroptosis
In this study, we demonstrated that omega-3 fatty acids reduced TNF𝛼 and IFN𝛾-induced
necroptotic gene expression. However, whether inhibition of mRNA abundance corelates to
protein translation and subsequent activity, remains unclear. It is therefore imperative we followup with protein analysis to properly conclude that omega-3 fatty acids are influencing
necroptotic signaling in a mixed bovine luteal cell population.
Ischemia-Reperfusion Model
Here, we proposed that the pattern of luteal blood flow (rapid hyperemia followed by a
slow decline) in response to PGF2𝛼 exposure resembles that of an ischemic-reperfusion event. If
PGF2𝛼 exposure indeed causes vasoconstriction and subsequent ischemia, we would expect the
effect to occur within the first 15 mins. Therefore, a study assessing luteal blood flow for the
entire 15 mins following PGF2𝛼 administration is imperative. If an ischemic event were to
succeed PGF2α exposure, then the percentage difference in luteal blood flow would decline
relative to the pre-infusion scan values.
Immune Cell Infiltration
While the purpose of the hyperemic event following PGF2α exposure remains unclear, it
appears to be a conserved portion of luteal regression. We demonstrated here that FM
supplementation appears to blunt and delay the PGF2α -induced hyperemic event. As such, we
are particularly interested in the biological processes occurring during the first hour post PGF2α
exposure, and how FM supplementation may be influencing these events. As was previously
discussed, immune cells play an apparent role during luteal regression (Pate et al., 2012; Pate &
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Keyes, 2001). An acute neutrophil and macrophage infiltration has been theorized to play an
important role in luteolysis (Penny et al., 1999; Shirasuna et al., 2012; Townson et al., 2002).
Omega-3 fatty acids have been shown to reduce adhesion molecule expression on endothelial
cells, and subsequently reduce immune cell infiltration, as reviewed by Calder (2012). Moreover,
during a pro-inflammatory event, immune cells release factors that aid in vasodilation to enhance
the immune response. Therefore, assessing changes in immune cell infiltration, as well as
phenotyping the immune cell population to distinguish between a net pro-inflammatory versus an
anti-inflammatory phenotype may provide insight as to how FM supplementation is luteal
protective, and why it is dampening the spike in luteal blood flow.
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